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Abstract 
Glycans are a diverse group of biological macromolecules that are made up of 
polysaccharides and glycoconjugates, such as glycoproteins and glycopeptides. 
The different types of glycans results in a multitude of structures, properties and 
functions. This investigation looks at the different hydrodynamic properties of 
several glycans including viscosity, sedimentation coefficient and molecular 
weight. These parameters are determined using techniques such as viscometry 
and Analytical Ultracentrifugation (AUC). 
A foundation on the principles of the techniques involved in hydrodynamic 
characterisation was provided through the use of ovalbumin, a glycoprotein that 
has been extensively studied. The study gave a basic understanding in Analytical 
Ultracentrifugation. 
Using the knowledge obtained from that investigation a study into possible 
reasons why the ‘last-resort’ glycopeptide antibiotic, vancomycin, is not commonly 
administered orally due to poor absorption within the gut. The study examined at 
the interactions of vancomycin with common macromolecules found with the 
gastro-intestinal tract, such as mucin, and trying to explain reasons how these 
interactions could inhibit the absorption of vancomycin. 
Finally investigations into two different species derived β-glucans, that have been 
shown to have medically benefiting properties, were characterised. The used of 
different hydrodynamic techniques yielded results that generally supported the 
accepted hydrodynamic properties of β-glucans, however there were results that 
challenged these understandings as well.  
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1 Introduction 
 
1.1 Overview 
Glycans are a diverse and complex group of biological macromolecules, composed 
of polysaccharides, oligosaccharides and glycoconjugates such as glycoproteins 
(Harding et al., 2017). The work presented throughout this MRes shows the 
hydrodynamic characterisation of four different types of glycans. 1) ovalbumin 
(glycoprotein), 2) vancomycin (glycopeptide) and 3) two β-glucans 
(polysaccharides) derived from oat and mushroom species. The aim of the study 
is to determine their intrinsic properties such as viscosity, molecular weight and 
sedimentation coefficients using hydrodynamic techniques.  
This study is concerned with the hydrodynamic characterisation of macromolecular 
glycans, where hydrodynamics can be defined as the study of a macromolecule’s 
movement through or with a solvent, which may be water or another aqueous 
medium (e.g. buffer solution). Although low in resolution compared to other 
techniques such as crystallography, hydrodynamics yields information regarding 
the general shape, structure and molecular weight of macromolecules in what for 
many is their natural environment (Harding, 1995). In order to look at the 
hydrodynamic properties of different macromolecular glycans several methods will 
be adopted for this investigation. The main methods adopted include viscometry, 
density measurement and Analytical Ultracentrifugation (AUC) as well as other 
methods.  
The main characterising instrument used in this investigation was AUC, consisting 
of two methods: sedimentation velocity (SV) and sedimentation equilibrium (SE).  
 
Sedimentation velocity is a method whereby a high rotor speed is applied in order 
to sediment any macromolecules present within a given system. Optical systems 
within the AUC track the rate of sedimentation (concentrations as a function of 
radius and time). The sedimentation data was analysed using the powerful 
algorithm SEDFIT(15b) which provides a platform for the analysis of sedimentation 
data against the Lamm equation (Lamm, 1929). The result of this analysis is that 
the distribution data is fitted to the best model that resolves the equation, this 
allows the sedimentation coefficient distribution and weight average sedimentation 
coefficient, s, for the given macromolecule to be obtained (Schuck, 2000). The 
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sedimentation coefficient can then be used to estimate the shapes of regular 
shaped macromolecules (such as globular proteins), using for example the ELLIPS 
suite of modelling algorithms (Harding et al., 1997b), or for more complex 
macromolecules the HYDRO suite of bead modelling algorithms (Garcia de la Torre 
& Harding, 2013). For flexible linear structures the HYDFIT set of algorithms are 
useful (Ortega & Garcia de la Torre, 2007)  
 
Sedimentation equilibrium (SE) is a method which involves the use of lower rotor 
speeds in order to reach an equilibrium point whereby the rate of sedimentation is 
matched by diffusion of the macromolecules. The lack of a net force in either 
direction results in no net movement of the distribution of macromolecules within 
the cell. The stationary state removes factors friction dependent factors including 
the shape of the macromolecule and is only dependant on the molar mass of the 
macromolecule (see, for example, Cole et al., 2008). The data obtained from the 
AUC is analysed using SEDFIT-MSTARv.1 which is an implementation of the MSTAR 
algorithm (Creeth & Harding, 1982) on the SEDFIT(15.b) platform and provides 
the weight average molar mass of the macromolecules (Schuck et al., 2014). 
In addition to AUC, other methods applied in this investigation include viscosity 
and density measurements, both of these hydrodynamic parameters are used 
within AUC analysis.  
The work in this dissertation investigates the hydrodynamic characterisation of 
three different glycans.  
Glycoproteins are a common glycoconjugate macromolecule found in nature. They 
are protein molecules with polysaccharides attached to the amino acid backbone. 
The attachment of polysaccharides to the protein occur during or post translation, 
and are sometimes required for the correct folding of the protein (Spiro, 2002).  
 
Ovalbumin is a glycoprotein that is the main constituent protein found in egg 
whites, it has a molecular weight of approximately 45,000 Daltons, of which the 
glycans make up approximately 4% by weight. The attachment of the glycans are 
made using N-linked glycosidic bonds to mainly asparagine residues on the 
ovalbumin molecule (An et al., 2003). Ovalbumin is a member of the serine 
proteinase inhibitor (SERPIN) family which includes enzymes such as antitrypsin 
(Carrell et al., 1985). Although a member of the SERPIN superfamily ovalbumin 
does not show any inhibitory activity towards serine proteases, this suggests that 
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its function is still not fully understood (Huntington et al., 2001). The lack of 
understanding in the function of ovalbumin is compensated by the well-defined 
structure and hydrodynamic properties of the protein macromolecule (Nisbet et 
al., 1981). Chapter 3 looks at obtaining a general understanding of different 
hydrodynamic analysis techniques through the characterisation of a preparation of 
ovalbumin. The investigation will determine some of the hydrodynamic properties 
of ovalbumin such as viscosity, density and sedimentation coefficients, using 
process including viscometry and analytical ultracentrifugation amongst other.  
Another related class of glycans are the glycopeptides. These are similar to 
glycoproteins however they are formed from only a few amino acids to which are 
attached oligosaccharides or in some cases polysaccharides (Hojo et al., 2007). 
Glycopeptides are used for a number of applications within nature, one of which is 
as antibiotics. The antibiotic properties of certain glycopeptides are of interest, 
especially with the emergence of antibiotic resistance within bacteria (Hiramatsu, 
2001). One such antibiotic glycopeptide of interest at the moment is vancomycin, 
this is a ‘last resort’ antibiotic used against gram-positive bacteria such as 
Staphylococcus aureus (MRSA) (Small et al., 1990). Vancomycin is a small 
glycopeptide with a molecular weight of 1449 Daltons, it is composed of several 
modified amino acids and a disaccharide of vancosamine-glucose (Jia et al., 2013). 
Vancomycin works through binding to the D-alanyl-D-alanine residues of 
peptidoglycan found in the gram-positive bacteria’s cell walls. The binding to the 
peptidoglycan inhibits cell wall growth and eventually leads to lysis of the bacteria 
cell. The binding of dimeric vancomycin to these residues has long been known, 
this investigation however looks at the characterisation of dimeric vancomycin in 
the absence of their ligand. 
The preferred administration method of vancomycin for patients is intravenously. 
Oral administration of vancomycin is less preferred as vancomycin is poorly 
absorbed within the intestine so has to be taken more frequently. This poor 
absorption has been known for a long time and common practice is to administer 
3 or 4 doses daily, if oral administration is necessary, however oral vancomycin 
often results in indigestion (Lucas et al., 1987 & Fekety et al., 1989). The reasons 
why vancomycin is poorly absorbed by the intestine are not fully understood. This 
study also investigates if vancomycin interacts with gastric mucin, a large 
glycoprotein and main component of the gastrointestinal tract (Kararli, 1995). The 
investigation will evaluate if any interaction with mucin could contribute to the 
poor absorption of vancomycin.  
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Chapter 5 involves the investigation of a class of the most common glycans found 
within nature, polysaccharides. These are long chain polymers composed of 
monosaccharide subunits. Polysaccharides normally have high molecular weights, 
high polydispersity and generally have less defined shapes and structures 
compared to proteins (Harding et al., 2017). The investigation involves a specific 
class of polysaccharide, β-glucan, derived from oat and wild mushroom species. 
These macromolecular glycans are of interest not only in foods but also in the field 
of health sciences as they have been shown, especially oat derived β-glucans, to 
aide in reducing cholesterol levels within the body (Ho et al., 2016).  
The basic structure of β-glucans are the same in all species. They are long chain 
polymers composed of D-glucose monomers. Although the monosaccharide 
subunits are the same between species, the glycosidic bonds that link them differ 
between species. Fungal β-glucans are often short chained polysaccharides linked 
through β,1-3-glycosidic bonds with β,1-6 branching, they tend to be low in 
molecular weight (Han et al., (2008) & Wasser, (2002)). Oat β-glucans tend to 
have high molecular weights resulting in them being structurally larger. In 
comparison to mushroom β-glucans, they form β,1-3 and β-1,4 glycosidic bonds 
(Brennan et al., 2005). The different glycosidic linkages found within the β-glucans 
result in different shapes and structures being adopted by both types. The 
differences in shape, combined with the different molecular weights, give varying 
hydrodynamic properties such as viscosity and sedimentation coefficients for each 
species.  The determination of the each β-glucans hydrodynamic properties are 
explored in Chapter 5 and compared.  
 
1.2 Investigation Aims  
 
The overall aim of this investigation is to use different hydrodynamic analysis 
methods to characterise several different types of glycans using methods including 
AUC and viscosity.  
 The aim of Chapter 3 is to understand how hydrodynamics and in particular 
AUC can assay for the purity/heterogeneity of a preparation of a 
glycoprotein - ovalbumin - with a low degree of glycosylation.  
 Chapter 4 aims to utilise and build on the hydrodynamic methods used in 
Chapter 3 to analyse the glycopeptide vancomycin. The investigations aims 
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to characterise the dimerisation of vancomycin and obtain a dissociation 
constant, as well as investigate the possible interaction with mucin. 
 Chapter 5 looks at the differences in the hydrodynamic properties of 
polysaccharides (i.e. glycans with 100% glycosylation) namely the relatively 
low molecular weight mushroom β-glucans and the relatively high molecular 
weight oat β-glucans. The investigation uses viscometry and AUC to 
determine viscosity, molecular weight and conformation. 
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2 Methods  
 
2.1 Density and Viscosity 
 
2.1.1  Density Theory 
Solution density measurements can be used in order to find several different 
parameters of a given macromolecule, including amongst others, the partial 
specific volume ( v¯ ) and the concentration of a sample. By measuring density we 
can also convert kinematic viscosities into dynamic (density corrected) viscosities 
(see Harding, 1997)  
The density of a macromolecular solution can affect its behaviour in a solution, 
such as viscosity behaviour as shown in equation (2.3). 
The density of a macromolecular solution can be used to find its partial specific 
volume. This is the reciprocal of the anhydrous density of the macromolecule. 
Proteins and polysaccharides have a v¯ value approximately 0.73 and 0.60 mL/g 
respectively (Hunter, 1966). In general polysaccharides are more dense than 
proteins therefore resulting in a lower partial specific volume. Equation (2.1) shows 
the relationship between density and partial specific volume (Kratky et al., 1973).  
 
(2.1) 
 
Where (ρ) is the density of the macromolecular solution, (ρ0) is the solvent density 
and c is the concentration of the sample (g/mL). Rearranging Equation (2.1) 
enable the concentration of a solution to calculate if the v¯ is known.  
 
(2.2) 
 
 
v¯ = 
1
ρ0
 × (1-
ρ - ρ0
c
 ) 
 
c = 
ρ - ρ0
1 - v¯ ρ0
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2.1.2  Density Measurements 
Density measurements were made using an Anton Paar DMA5000 oscillating 
capillary meter.  Samples were purged after entry into the density meter 
(approximately 2mL) ensuring no air bubbles were present within the capillary. 
The samples were left to equilibrate to 20.00°C whereupon the density 
measurements were recorded to seven significant figures. 
 
2.1.3  Viscosity Theory 
Viscosity is a measure of a solutions resistance to flow, such that a more viscous 
material (e.g. honey) flows more slowly than a less viscous material (e.g. water). 
The intrinsic viscosity [η] relates to the viscosity of a macromolecule in solution. 
It is a measure of the shape and size of the macromolecule and is derived through 
the flow times of solutions using the relative viscosity (ηr): 
 
(2.3) 
 
where η and η0 are the dynamic viscosity of the solution and solvent, t and t0 are 
the flowtimes of the solution and solvent and ρ and ρ0 are the solution and solvent 
densities respectively. The density correction is important for solution 
concentrations >5mg/mLs.  
From the relative viscosity the reduced viscosity (ηred) can be determined using 
the concentration of the solution (c):  
(2.4) 
 
In conjunction with the reduced viscosity, the inherent viscosity (ηinh) is another 
method for determining the intrinsic viscosity using the natural logarithm of the 
relative viscosity: 
 
(2.5) 
 
 
ηr = 
η
η0
= (
t
t0
 × 
ρ
ρ0
) 
 
ηred = 
(ηr − 1)
c
 
ηinh = 
ln(ηr)
c
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Both the reduced and inherent viscosities are dependent on concentration as a 
result of non-ideality. This can occur through different mechanisms including 
charge interaction and size exclusion. In order to eliminate the effect of non-
ideality the reduced and inherent viscosity are plotted against concentration, with 
extrapolations of both data sets to zero concentration. Upon approaching zero 
concentration non-ideality is reduced to almost zero as the possible interactions 
between macromolecules are reduced as to almost be negligible. Therefore the 
value of the reduced and inherent viscosities at zero concentration is termed as 
the intrinsic viscosity [η]. 
Both the reduced and inherent viscosities extrapolated to ideal conditions (c=0) 
should produce the same intrinsic viscosity value, Figure 2.1 illustrates this. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Huggins and Kraemer extraction for intrinsic viscosity. 
Reduced viscosity (●) and inherent viscosity (▲) vs concentration for 
irradiated (10kGy) guar in phosphate chloride buffer (pH 6.8, I = 0.10). 
The 'common' intercept gives [η], the slopes KH [η]2 and KK [η]2 (from 
Jumel, 1994). 
 
 
 
9 
 
  
(2.6) 
 
From the plot of the reduced and inherent viscosities, Figure 2.1, two parameters 
can be determined the Huggins and Kraemer constants KH and KK respectively 
(Sakai, 1968). Equations (2.7 & 2.8) show the relationship between the reduced 
viscosity and Huggins constant and between the inherent viscosity and the 
Kraemer constant, respectively (see Harding, 1997). 
  
(2.7)  
 
(2.8) 
 
A combination of the Huggins and Kraemer equations is the Solomon-Ciuta 
equation (2.9).  
 
(2.9) 
 
which allows an approximate estimation of [η] if only a single concentration has 
been measured. When plotted against concentration as in Figure 2.1, a linear line 
that lies between the reduced and inherent viscosity extrapolations occurs. Figure 
2.2 illustrate this. 
 
 
 
 
 
 
lim
c→0
( ηred )= lim
c→0
( ηinh )=[η] 
 
 
ηred=[η](1+[η].KH.c)         ,         KH= (
slope
[η2]
) 
 
 ηinh=[η](1 − [η].KK.c)         ,         KK= - (
slope
[η2]
) 
 
[η] = (
1
c
) × [ 2(ηr -1) - 2ln(ηr)] 
1
2 
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Figure 2.2: Illustration of Solomon-Ciuta plot. Huggins (black), Kraemer 
(red) and Solomon-Ciuta (green) extrapolations for λ870 intrinsic 
viscosity plot (from Jumel, 1994). 
2.1.4  Viscosity Measurements 
As stated in 2.1.3 the flow times of macromolecular solutions need to be measured 
in order to determine the intrinsic viscosity through parameters such as the 
relative viscosity (see, Harding, 1997). 
To accurately measure the flow times of the samples they were placed into a glass 
Ostwald U-tube viscometer (Figure 2.3). A number of variables can affect the 
viscosity of a solution the biggest being temperature, therefore in order to 
eliminate this possibility the U-tube was placed into a water bath regulated by a 
Grant GD120 heater pump at (20.00+ 0.05)°C. The samples were then injected 
into the reservoir of the U-tube (approximately 2mL) and left to adjust to the water 
bath temperature.  
In order to measure the flow times the U-tube was connected to a Schott-Gerӓte 
AVS 400 pump and timing unit. The samples were pumped through the capillary 
of the U-tube to the top of the measuring well. The samples were then allowed to 
flow back through the capillary under the force of gravity alone. The time taken 
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for the meniscus to move from the top of the well to the bottom was recorded by 
the optics of the AVS 400 (refer to Figure 2.3 (a)).  
 
    
 
 
 
 
 
 
 
 
 
Figure 2.3: Depictions of Ostwald viscometer. (a) A the top of the 
measuring well, B the bottom of the measuring well, C U-tube reservoir. 
(b) Physical depiction of U-tube viscometer (from Poggio et al., 2015) 
Using the flow times, and subsequent corresponding density measurements, the 
relative viscosity can be determined through Equation (2.1). 
 
2.2  Concentration Determination 
 
2.2.1   UV Spectrophotometry 
Concentration is critical in determining many parameters of a macromolecule, 
therefore it is essential to accurately measure this parameter. UV 
spectrophotometry is a method which determines the concentration of a solution 
through the Beer-Lambert law, Equation (2.10); 
 
    (2.10) 
 
A = ε280nm . L . c        ,          c = 
A
ε280nm . L 
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Where A is the absorbance of the solution, ε280nm is the extinction coefficient of the 
macromolecule at 280nm (L mol-1 cm-1), L is the path length (cm) and c is the 
concentration of the solution (g/mL).   
The Beer-Lambert law is useful for determining the concentration of 
macromolecule solutions which have a chromophore within their structure. 
Chromophores absorb UV light, it is the absorption (change in light intensity) of 
the UV light that the spectrophotometer detects. The change in light intensity is 
directly proportional to the concentration of the solution. 
Although the Beer-Lambert law can be applied to macromolecules such as proteins, 
it is not possible to use this technique on polysaccharides as they do not contain a 
chromophore within their structure.  
Measurements of the UV absorption were performed using a Varian Cary-50 Probe 
UV-Vis Spectrophotometer. Samples were placed into a 1mL reduced volume 
quartz cuvette and placed into the spectrophotometer. Measurements were made 
using a wavelength of 280nm. This was chosen as the chromophores in proteins 
are aromatic groups found on phenylalanine, tryptophan and tyrosine amino acids 
and absorb UV light at this wavelength. 
2.2.2   Refractometry 
Refractometry is another method which can measure the concentration of a 
macromolecule solution by using a refractometer. This method can be applied to 
most macromolecule solutions as it does not rely on the presence of 
chromophores. For this purpose it is the predominant method for determining the 
concentration of polysaccharide solutions.  
Refractometry works on the principle that all macromolecular solutions bend the 
direction light at different amounts. For a given wavelength this depends in the 
concentration and the refractive index (dn/dc). The bending of light is affected by 
the refractive index of the molecule as well as the concentration of the solution, 
the higher the concentration the greater the bending of the light. Using this 
principle the concentration of a solution can be made using Equation (2.11). 
 
(2.11) 
 
Concentration = Brix(%)× (
(
dn
dc
) molecule
0.15
) × 10 (mg/mL)  
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Where Brix (%) is the percentage measure and 0.15 is the dn/dc of sucrose in 
mL/g (used as a standard). 
Measurements were made using an ATAGO DD-7 differential refractometer. The 
apparatus was zeroed by purging approximately 3mL of the solvent through the 
refractometer. Once blanked, solution measurements were made in the same way, 
Brix (%) were recorded for each measurement. 
 
2.3   Analytical Ultracentrifugation 
Analytical Ultracentrifugation (AUC) is a quantitative technique for measuring 
solutions of macromolecules. AUC works on the principle that under a centrifugal 
force, molecules with different molecular weights and shapes separate and 
sediment through a solvent at different rates. The rate of sedimentation is largely 
affected by the mass of the macromolecule. The greater the molar mass the faster 
the molecule sediments (Svedberg et al., 1926). As explained in Chapter 2 there 
are 2 types of AUC measurements; sedimentation velocity (SV) and sedimentation 
equilibrium (SE). Each method provides different information of the hydrodynamic 
properties of the macromolecule being analysed. 
 
2.3.1   Theory 
2.3.1.1 Sedimentation Velocity (SV) 
Herein lies a summary of the method taken from (Ralston, 1993) Sedimentation 
velocity involves the application of a large centrifugal force to a macromolecular 
solution over a period of 12 -18 hours. The force is applied through spinning the 
solution at a high rotor speed and the sedimentation is tracked using absorbance 
or Rayleigh interference optics. 
The high rotor speeds allow the macromolecules to sediment. The rate of 
sedimentation, divided by the force applied, is termed the sedimentation 
coefficient (s) of the macromolecule. Sedimentation coefficients are dependent 
upon the size and shape of the macromolecule. Generally, the larger the 
macromolecule the faster it sediments thus a larger sedimentation coefficient 
(Svedberg et al, 1926). The Svedberg equation in Equation 2.12 shows the 
relationship between molar mass and sedimentation coefficient. 
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(2.12) 
 
 
 
where (s) is the sedimentation coefficient, (v) is the boundary terminal velocity, 
(ω) is the angular velocity (radians/second), (r) is the radius from the centre of 
rotation, (M) is the molar mass,( v¯ )is the partial specific volume, (ρ0) is the solvent 
density, (NA) is Avogadro’s number and (f) is the frictional coefficient. 
In monodisperse solutions the rate of sedimentation should be uniform as the 
macromolecules are the same molecular weight. However polydispersed systems 
often show a non-uniform sedimentation profile. This is due to the macromolecules 
having different molecular weights and shapes that result in different 
sedimentation rates. 
In addition to the effects of mono and polydispersity the effects of the solvent on 
the sedimentation of the macromolecules have to be taken into account. The 
solvent will have its own viscosity and density which will affect the sedimentation 
rate of the macromolecule. Therefore in order to overcome this the sedimentation 
coefficient is often corrected to standard solvent conditions, namely the viscosity 
and density of water at 20.0°C. Equation (2.13) shows the correction equation, 
where the subscripts (20,w) denotes the corrected values and (T,b) are the 
experimental values obtained. 
 
(2.13) 
 
Sedimentation velocity data was analysed using the computer programme SEDFIT 
(Schuck, 2000). This aims to fit a model to the data to a ‘best fit’ that yields the 
most accurate sedimentation coefficient. In order to model the data SEDFIT uses 
two algorithms; the least square Gaussian distribution (ls-g*(s)) and continuous 
distribution (c(s)). The two algorithms are based upon the Lamm equation (2.14) 
(Lamm, 1929). The equation is used to fit the data to the best solution to the 
equation which describes the shape of the boundaries formed through 
sedimentation. 
s = 
ν
ω2r
 = 
M(1- v¯ ρ0)
NAf
  
s20,w = 
(1- v¯ρ )20,w
(1- v¯ρ )T,B
× 
ηT,B
η20,w
 × s T,b  
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(2.14) 
 
Equation (2.14); D is the diffusion coefficient, c is the concentration, r is the radial 
position and t is the time. 
In order to determine the best model for the data, using either ls-g*(s) or c(s) 
analysis, SEDFIT removes time invariant (TI) and radial invariant (RI) noise. The 
removal of this noise increases the resolution of the data and represents the data 
more accurately (Schuck et al., 1999).  
The least square Gaussian distribution algorithm analyses the raw SV data against 
a number of parameters and models it against s. The modelling of the data does 
not take into account the diffusion of the macromolecules within the solution, this 
means that the model is not fully representative of what is happening during 
sedimentation within the cell. The result of diffusion not being taken into account 
results in the broad peaks on the plot, however even though the peaks are 
relatively broad they give a good indication of the sedimentation coefficient.  
 
The so-called c(s) analysis uses a similar algorithm however it takes into account 
diffusion. The impact of diffusion on very large macromolecules is small and in 
some cases negligible. The greater impact comes when smaller macromolecules 
are in solution (Schuck, 2000). The diffusion coefficient is determined by finding 
the frictional ratio of the macromolecule. The frictional ratio is the frictional 
coefficient of the observed macromolecule to that of a perfect sphere of the same 
molecular weight (Brown et al., 2006). With the addition of diffusion within the 
algorithm more defined peaks are often observed within the c(s) distribution. This 
has benefits in providing more accurate sedimentation coefficients, however it can 
also lead to over-sharpening of some peaks that may not be accurate (Schuck, 
2000). The addition of diffusion within the calculation also results in c(s) 
distributions being able to estimate the weight average molar mass by 
transforming c(s) distributions into c(M) vs M plots. This is applicable for systems 
of low polydispersity (e.g. mixtures of proteins) and where the components have 
similar diffusion coefficients. Continuous distributions we use a different 
programme call the Extended Fujita method (Harding et al., 2011). 
 
dc
dt
= D [(
d
2
c
dr
2
) + 
1
r
. (
dc
dr
)] - sω2. [r (
dc
dr
) +2c]   
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Sedimentation velocity analysis for monodispersed systems, such as proteins, 
yield sharper more defined peaks as there is only one macromolecule species in 
solution, allowing a higher degree of accuracy in the estimation of the 
sedimentation coefficient. However polydispersed systems, such as 
polysaccharides, or heterogeneous preparations of a protein or glycoprotein, 
produce more broad peaks with a lower degree of sharpness as there are multiple 
macromolecules with different molecular weights. This results in an average 
sedimentation coefficient being obtained. In addition the areas under the curves 
for both g(s) and c(s) are related to the concentration of the macromolecules 
within the cell. 
In order to obtain more accurate sedimentation coefficients concentration series 
are prepared, this is to reduce non-ideality factors affecting the sedimentation 
rate. The results are plotted as s (or 1/s) vs concentration with an extrapolation 
to zero concentration as to obtain the actual sedimentation coefficient independent 
of concentration. 
 
2.3.1.2 Sedimentation Equilibrium (SE) 
 
Sedimentation equilibrium experiments involve solutions of macromolecules being 
centrifuged at lower speeds than in SV runs. The balance between sedimentation 
and diffusion, results in no overall net movement of the macromolecules within the 
cell (for example Cole et al., 2008; Schuck et al., 2014). The choice of speed for 
equilibrium runs is of paramount importance. Too high or too low and the 
macromolecules either sediment or diffuse, respectively. Therefore in order to 
ascertain an appropriate equilibrium speed the results of the SV analysis are often 
used, which through s can give an idea of the approximate size. 
Once equilibrium is achieved, the shape of the macromolecule is no longer an 
important factor as there is no longer any net movement of the macromolecule 
within the cell, and no frictional resistance to flow. That shape of the 
macromolecule only affects the time taken to reach equilibrium. Therefore, from 
equilibrium runs the major factor that can be determined is the weight average 
molar mass (Van Holde & Baldwin, 1958). 
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The data gathered from the AUC, using either absorbance or Rayleigh interference 
optics, were analysed using the computer platform SEDFIT-MSTAR.v1. The 
algorithm employs the integral function M* of Creeth and Harding (1982) 
 
(2.15) 
 
where c(r) is the local concentration at radial position r, c(a) is the meniscus 
concentration, and k is the constant depending on the rotor speed, buffer density, 
the temperature and partial specific volume. 
 
The M* function provides a convenient way of estimating the weight average 
molecular weight (Mw) over the whole macromolecular distribution in the cell from 
the identity of M*(r→b) = Mw, where b is the radial position at the bottom of the 
cell. By extrapolating the M* function to r=b we can obtain the Mw. Furthermore 
the SEDFIT-MSTAR algorithm evaluates the local weight average molecular weight 
at individual radial positions r (and hence local concentration c(r)) in the cell. These 
are obtained from the local slopes of the lnc(r) vs r2 curves (Schuck et al., 2014). 
This also provides another method of obtaining the weight average over the whole 
distribution Mw from the "hinge point", the value of Mw(r) when c(r) = the initial 
loading concentration, c. The values obtained for the M* and hinge point weight 
average molar masses should be similar to each other. 
 
As with SV runs the data contains TI and RI noise, which are removed in the same 
way as to increase the resolution of the data. In addition to this distortion of the 
profiles can occur (through e.g. window imperfections at high speeds), in order to 
overcome this a baseline needs to be determined. This involves the recording of 5 
initial scans taken as soon as the equilibrium speed has been attained and over a 
short period of time (~5 minutes) and averaging them, then repeating this process 
once the final equilibrium concentration distribution has been reached. The 
average initial scan is then subtracted from the average final scan, establishing a 
baseline with which SEDFIT-MSTAR works upon.  
 
 
M*(r) = 
(c(r) - c(a))
kc(a).(r2 - a2) + 2k ∫ r [c(r) - c(a).dr]
r
a
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2.3.2   Apparatus 
 
2.3.2.1 Analytical Ultracentrifuges 
Sedimentation velocity and equilibrium experiments were conducted on a Beckman 
Optima XLI ultracentrifuges. The ultracentrifuges contain a vacuum chamber 
where the samples are placed, the use of a vacuum removes air and reduces air 
frictions reducing any temperature increases whilst running. The temperature of 
the chamber is set and maintained to within ±0.1°C. The drive unit within the 
ultracentrifuge has a top speed of 60,000rpm and can be fitted with one of two 
titanium rotors for runs, a 4 hole An-60Ti or 8 hole An-50Ti, which holds 3 or 7 
cells respectively as well as an additional counterbalance cell.  
The Beckman operating software ProteomeLab v6.2 is used to setup the AUC 
methods.  
2.3.2.2 Analytical Cells 
Sedimentation velocity experiments were predominantly carried out using two 
channel 12mm epoxy resin centrepieces and two sapphire windows on either side, 
enclosed within an aluminium case. The windows were placed into the aluminium 
case with plastic gaskets and an aluminium screw top. Sedimentation equilibrium 
experiments used longer aluminium cases that could accommodate a two port 
20mm titanium centrepiece and sapphire windows. The windows were assembled 
in the same manner however an extra protective gasket was placed between the 
window and the titanium centrepiece, protecting the window. 
Both cell types were tightened to a torque of 130lb and then filled. The 12mm cells 
generally had 400μL of sample injected into the left hand port and likewise with 
the buffer in the right side port. The 20mm cells employed the same method but 
used volumes of 150μL. Once filled, the sample injection ports were sealed with 
butyl rubber discs and aluminium screws.  
2.3.2.3 Optical System 
In order to analyse the movement of the macromolecules during centrifugation an 
optical measuring system was used. The system involves the use of a high 
precision monochromator that takes absorbance and Rayleigh interference 
measurements. All measurements were recorded and translated using ProteomLab 
v6.2.  
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As stated in 2.2.1 absorbance measurements are useful for macromolecules with 
chromophores, such as proteins or glycoproteins, as they absorb UV radiation. The 
absorbance optics measure along the path length of the cell, taking approximately 
2 minutes for each cell. The data collected shows the intensity difference 
(absorbance) within the solution as the macromolecules start to sediment. 
Rayleigh Interference measurements involve the use of monochromatic light as 
opposed to UV light as in absorbance. The interference measurements were made 
along the path length of the cell again, however the data is used to produce fringe 
patterns. The fringe patterns were optimised before the samples were spun at high 
speed. Optimisation typically took place at 3000rpm. Once optimised, the rotor 
speed was increased and measurements were taken. The sedimentation of the 
macromolecules produces a boundary within the cell between the sedimenting 
sample and the solvent, the change in boundary position within the cell is 
measured by the interference optics and relates to the sedimentation coefficient 
of the macromolecule. 
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3 Hydrodynamic Analysis of an Ovalbumin preparation 
 
3.1   Introduction 
Egg whites make up approximately 66% of the mass of eggs, it protects the egg 
yolk in early development and as a source of nutrition and protein for developing 
embryos. The main protein within egg white is ovalbumin, a glycoprotein 
constituting around 54% of the dry mass of the egg white (Mine, 1995). The 
function of ovalbumin is not fully understood, however it is thought it acts as a 
storage protein (Huntington et al., 2001) 
Ovalbumin is a glycoprotein with a protein backbone consisting of 385 amino acids 
giving a molecular weight of 42.69 kDa, however the additional carbohydrates 
attached give an overall molecular weight of 44.29 kDa (Nisbet et al., (1981) & 
Tai et al., (1977)). However these values have slight variation between species. 
The protein backbone of ovalbumin is bonded to the glycans through N-glycosidic 
bonds on residues containing amine groups. One such residue is asparagine (Asn) 
292 which has been shown to form such linkages, another possible site that has 
been identified is asparagine 317 (Harvey et al., 2000 & Huntington et al., 2001). 
The composition of the glycans attached to ovalbumin have been shown to contain 
high levels of mannose (Man) and N-acetylglucosamine (GlcNAc) monomers, 
common structures found to be adopted include (Man)5(GlcNAc)2 and 
(Man)6(GlcNAc)2 (Neuberg (1938) and Tai et al. (1977)). Figure 3.1 shows the 
structure of one of the main glycans. The glycosylation of ovalbumin accounts for 
approximately 4% the dry weight of the molecule, therefore the protein is lightly 
glycosylated (Kiely et al. 1976). 
 
 
 
 
 
Figure 3.1: Main structural template of the N-linked glycans attached to 
ovalbumin, (GNAc = N-acetylglucosamine). Obtained from Kiely et al. 
(1976). 
21 
 
Although ovalbumin has a low level of glycosylation, the residues that are present 
may have a structural impact on the protein-protein level. N-acetylglucosamine is 
a mainly hydrophobic molecule which can form ‘sticky patches’ that can bind to 
other hydrophobic regions, allowing for the self-associations of macromolecules to 
occur (Ramakrishnan et al. 2012). Through these ‘sticky patches’ it is possible that 
ovalbumin can form weak dimers. A study by Ianeselli et al. (2010) showed that 
ovalbumin can readily form dimers in solutions of either no or very low salt 
concentrations.  
 
3.1.1   Aim of Investigation 
The aim of this part of the study is to use viscosity, sedimentation velocity and 
sedimentation equilibrium measurements to determine the hydrodynamic 
characteristics of a preparation of ovalbumin in terms of its heterogeneity. 
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3.2   Materials and Methods 
 
3.2.1   Materials 
 
A 1L phosphate buffered saline (PBS) solution of pH 7.0 was prepared using 2.923g 
sodium chloride, 1.561g dihydrogen potassium orthophosphate and 4.595g 
sodium dihydrogen dodecahydrate, obtained from Sigma Aldrich, UK.    
Ovalbumin (98% purity) was purchased from Sigma Aldrich, UK. A 15mL 10mg/mL 
stock solution of ovalbumin was prepared using 150mg of ovalbumin and PBS 
buffer.  
 
3.2.2   Ovalbumin sample preparation and concentration determination 
A stock solution of ovalbumin at a nominal concentration of 10mg/mL in PBS buffer 
was prepared. 
The concentrations of the samples was determined using a Cary-50 UV 
spectrophotometer, measuring at a wavelength of 280nm which was zeroed using 
PBS buffer. Prior to each measurement each concentration was diluted by taking 
0.2mL of their respective stock and adding PBS to achieve their respective stock 
volumes, this gave a different dilution factor for each concentration. Diluted 
samples were then placed into reduced 1mL quartz cuvettes and placed into the 
spectrophotometer, readings were taken until 5 relatively close absorbance values 
were achieved.  
Concentrations were determined using Equation 2.10, with an extinction coefficient 
of 660g/ml cm-1, the absorbance value given was then multiplied by the dilution 
factor to give the stock concentration of each dilution.  
3.2.3   Density and Viscosity Measurements 
Density measurements were carried out using the 2mL extract of each 
concentration. Measurements were made using the Anton Paar DMA5000 density 
meter, following the method outlined in (2.1.2). The densities were recorded until 
3 stable readings were obtained and averaged.  
Viscosity measurements were conducted using an Ostwald capillary viscometer, 
using the 2mL extract of each concentration and the PBS buffer. The samples were 
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injected into the U-tube reservoir, 2mL, and placed into the water bath at 20°C. 
The flow times of the samples was recorded by the timing unit outlined in section 
2.1.4. 
3.2.4   Sedimentation Velocity 
Sedimentation velocity analysis was carried out using the Beckman XL-I AUC. To 
reduce the effects of non-ideality a low concentration ovalbumin solution, 
0.5mg/mL, was analysed.  
The samples were loaded into the 12mm aluminium epoxy centrepiece XLI cells, a 
volume of 0.4mL 0.5mg/mL ovalbumin and 0.4mL of PBS buffer was loaded into 
each cell. The cells were inserted into the 4 hole rotor and then into the AUC set 
at 20.0°C. An initial rotor speed of 3000rpm was applied to check that all cells 
were fine and to allow the vacuum to be reached. A rotor speed of 45,000 rpm 
was used with measurements made using Rayleigh interference optics. Scans were 
taken at 2 minute intervals for each sample until 500 scans of each sample were 
acquired. The data was analysed using SEDFIT producing both ls-g*(s) and c(s) 
analysis (refer to section 2.3.1.1). Within the parameters a buffer density of 
1.0032g/mL and a v¯ value of 0.748mL/g were used (Harding, 1981). 
3.2.5   Sedimentation equilibrium 
Sedimentation equilibrium was carried out using the Beckman XL-I AUC, three 
20mm titanium centrepiece cells were constructed. The cells were loaded with 0.15 
mL of 0.5 mg/mL ovalbumin and 0.15 mL of PBS buffer. 
The samples were centrifuged at 20,000 rpm over 3 days at 20°C, measurements 
were made using Rayleigh interference optics every 1 hour.  The data was analysed 
using SEDFIT-MSTAR (Schuck et al., 2014), using the average if the final 5 scans 
(refer to section 2.3.1.2).  
A subsequent SE run was performed in the same manner as before, however a 
1.5mg/mL ovalbumin solution was examined. Both runs had the same parameters 
of 1.0032 g/mL for buffer density and a v¯ of 0.748 mL/g. 
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3.3   Results and Discussion 
 
3.3.1   Concentration measurements 
The actual concentrations of the ovalbumin solutions were determined through 
spectrophotometry, using Equation (2.10) and multiplying the result by the 
relevant dilution factor. The extinction coefficient used for ovalbumin was 660 
mL.g-1.cm-1. The values obtained for the actual concentrations were very close to 
the weighed out nominal concentrations, Table 3.1 shows the results and 
calculated actual concentrations of the samples.  
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Figure 3.1: Absorbance readings for ovalbumin solutions and subsequent determination of actual concentrations. 
 
 
 
 Absorbance Readings   
Nominal 
conc 
(g/mL) 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
Average 
 
DF 
 
Actual conc 
(g/mL) 
 
0.01 
 
0.0871 
 
0.0875 
 
0.0872 
 
0.0880 
 
0.0877 
 
0.0875 
 
75 
 
0.0099 
0.009 0.0915 0.0909 0.0913 0.0911 0.0910 0.0912 65 0.0089 
0.008 0.0921 0.0922 0.0914 0.0919 0.0915 0.0919 55 0.0077 
0.007 0.0916 0.0914 0.0916 0.0913 0.0911 0.0915 45 0.0062 
0.006 0.1034 0.1033 0.1032 0.1031 0.1032 0.1032 35 0.0055 
0.005 0.1279 0.1284 0.1284 0.1282 0.1280 0.1282 25 0.0049 
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3.3.2   Density and Viscometry 
Density measurements were recorded for the ovalbumin concentrations 
and PBS buffer, these were used to calculate the density correction ratio 
(ρ/ρ0) for the determination of the intrinsic viscosity. The densities and 
correction values for each concentration are laid out in Table 3.2. 
Table 3.1: Density measurements for varying concentrations of 
ovalbumin in PBS at 20.0°C 
The flow times of the ovalbumin solutions were used to determine the 
relative, reduced and inherent viscosities using Equations (2.3, 2.4 & 2.5) 
respectfully, refer to Table 3.3 for values.  
Table 3.3: relative, reduced and inherent viscosities of ovalbumin 
in PBS at 20.0°C 
 
Nominal 
concentration 
(g/mL) 
Readings (g/mL)     
1 2 Average  ρ/ρ0 
0.01 1.00576 1.00577 1.00576 1.003457 
0.009 1.00538 1.00541 1.00539 1.003090 
0.008 1.00484 1.00452 1.00468 1.002374 
0.007 1.00467 1.00467 1.00467 1.002363 
0.006 1.00380 1.00390 1.00385 1.001545 
0.005 1.00345 1.00346 1.00345 1.001149 
PBS 1.00326 1.00135 1.00230   
 
Nominal 
concentration 
(g/mL) 
Relative 
viscosity, ηr  
(mL/g) 
Reduced 
viscosity, ηred 
(mL/g) 
Inherent 
viscosity, ηinh 
(mL/g) 
0.01 1.06 6.11 5.93 
0.009 1.05 6.05 5.86 
0.008 1.04 5.76 5.64 
0.006 1.03 5.96 5.87 
0.005 1.02 5.24 5.18 
 
 
27 
 
Using the reduced and inherent viscosities plotted against actual 
concentration and extrapolated to zero concentration the intrinsic viscosity 
was found to be (5.0± 0.15) mL/g, and Figure 3.2 shows the extrapolation 
determination. According to studies by Koseki et al. (1989) the intrinsic 
viscosity value for (monomeric) ovalbumin is between 4.2 – 4.5 mL/g.  
Figure 3.2: Extrapolation to zero concentration of reduced and 
inherent viscosities of ovalbumin at 20.0°C. The y-intercept is the 
intrinsic viscosity value [η]. 
The larger value obtained through this study can be attributed to 
heterogeneity within the ovalbumin sample, possibly due to the presence 
of some dimers. This is borne out by the sedimentation velocity results. 
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3.3.3   Sedimentation Velocity 
 
The data from the sedimentation velocity run for the ovalbumin was 
analysed using SEDFIT, the results of the run are shown in Figure 3.3. The 
top plot shows the ls-g*(s) against s distribution, the bottom plot shows 
the c(s) against s distribution. 
Figure 3.3: Sedimentation velocity analysis for ovalbumin 
concentration series. Top: ls-g*(s) analysis. Bottom: c(s) analysis. 
The distribution results from the ls-g*(s) plot shows that the ovalbumin 
solutions are predominantly monodispersed, this is indicated through the 
appearance of only 1 main peak at (3.2± 0.3) S. The main peak at 3.2 S 
makes up approximately 92% of the total signal, indicating that the 
macromolecule responsible for the peak makes up ~92% of the solution. 
The sedimentation coefficient obtained from the study is very similar to 
values obtained from Polson et al. (1967), the study showed that 
ovalbumin has a sedimentation coefficient of 3.15 S at 42,000 rpm. This 
value is very similar to the value obtained in this study. However the g(s) 
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vs s and c(s) plots show significant amounts of low molecular weight 
contaminants (s~1.5S) and what appears to be a dimer (s ~ 4.5 S). 
The lower plot of Figure 3.3 shows the c(s) distribution of ovalbumin. As 
stated in 2.3.1.1 c(s) analysis includes diffusion within the algorithm giving 
more defined peaks, when applied to this data the single peak shown by 
the ls-g*(s) analysis shows that it is composed of 3 peaks; Peak 1 (1.5 S), 
Peak 2 (3.2 S) and Peak 3 (4.5 S). Peak 1 at 1.5 S is likely a result of 
undialysed small molecular weight contaminants 
Peak 2 on the distribution is relatively narrow with defined ends yielding 
an s value of approximately 3.2 S. The sedimentation coefficient supports 
the sedimentation coefficient value obtained ls-g*(s) distribution, as well 
as falling within the limits of the study conducted by Polson et al. (1967). 
The s value also indicates that the majority of the material in solution is 
monomeric ovalbumin. 
Peak 3 although small, indicates that there are molecules present with a 
sedimentation coefficient of ~4.5 S. The main explanation for this is that 
some of the ovalbumin has formed dimers, as stated in 3.1 the likely 
occurrence for dimerisation is the bonding of two ‘sticky patches’ on 
ovalbumin monomers. As shown in the study by Ianeselli et al. (2010) at 
low salt concentration ovalbumin can form dimers, from the c(s) 
distribution it is evident that the 0.1M PBS buffer is sufficiently low enough 
to allow low level of dimerisation.  
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3.3.4  Sedimentation Equilibrium  
Sedimentation equilibrium data was analysed using SEDFIT-MSTAR for all 
samples. As stated in 2.3.1.2 a baseline was established in SEDFIT-MSTAR 
by subtracting the first 5 initial scans from the last 5 scans, the baseline 
corrected data was then used to determine the molar mass. Figure 3.4 
shows the 4 plots based upon the SEDFIT-MSTAR algorithm (Schuck et al., 
2014) for one of the 0.5 mg/mL ovalbumin samples; they show ln(c) vs r2, 
M* vs r and MW,app(r) vs r or c(r).  
Figure 3.4: Molar mass analysis for 0.5 mg/mL ovalbumin from 
SEDFIT-MSTAR: (a) log of concentration in the cell vs the square 
radial displacement, (b) M* analysis vs radius, (c) point average 
molecular weight vs local concentration c(r) in the ultracentrifuge 
cell, (d) point average apparent molecular weight vs radial position 
in the cell.  
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The data shown in Figure 3.4 shows not only the molecular weight of the 
ovalbumin but other factors as well. Plot (a) show the natural logarithm of 
the data against the square of the radius. The raw data (black) and the 
fitted data (red) lay directly on top of each other, this is an indication that 
the sample is predominantly monodispersed. There is a small degree of 
noise on the data that suggests other molecules are present.  
 
Plot (b) shows the M* analysis plot. The weight average molar mass over 
the whole distribution is obtained from extrapolating the M* function to 
the cell base (Creeth & Harding, 1982), using the identity M*(r→b) = Mw. 
A value of (44.6±1.5) kDa is obtained.   
 
Plots (c) and (d) show the molecular weight apparent as a function of 
loading concentration and radius, respectfully. Both plots show a similar 
weight of approximately 45kDa, both the raw and fitted data shows a flat 
line indicating the sample is again monodispersed. Similar to the M* plot 
(b), there is noise within the data indicating that there is extra material 
within the sample other than monomeric ovalbumin.  
Using the data from the Mw,app (r) vs r and Mw,app (r) vs c(r) plots the hinge 
point molecular weight can be calculated, for this sample the value was 
calculated to be approximately 45.7kDa. The value obtained is very similar 
to the value obtained from the determination of Mw from the M* plot.  The 
whole distribution Mw values obtained at loading concentrations of 
0.5mg/mL (3 repeats) and 1.0mgmL (repeats) from the M* and hinge 
methods are compared in Table 3.4.  
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Table 3.2: Summary of weight average Mw results for 0.5 and 1.0 
mg/mL ovalbumin samples, centrifuged at 20,000rpm. 
 
The results show that despite the presence of low molecular weight 
contaminants (totally ~8% as evident from the sedimentation velocity 
analysis), the overall weight average molecular weight for ovalbumin is 
close to the sequence value for the molar mass of ovalbumin (44.3kDa) 
 
3.3.5   Shape Determination 
The ELLIPS1 algorithm of Harding et al (2005), Harding and Garcia de la 
Torre (2013) was used in the shape determination.  
The first parameter that needs to be determined is the swollen specific 
volume (vs) this is derived using Equation (3.1). 
 
(3.1) 
 
where v¯ was taken as 0.748 mL/g, ρ0 (solvent density) was 1.0023 and δ 
was the hydration of ovalbumin. The value for the hydration was derived 
from a study by Harding (1981) which used a hydration value of 0.57. 
Using the values of the experiment and Equation (3.1) a vs of 1.32mL/g.  
The determination of the Perrin function were calculated used BIOMOLS2 
(Gillis, private comm.), which required several parameters; v¯, vs, ρ0, the 
frictional ratio (f/f0) determined using the sedimentation coefficient, and 
vs = 
v¯ + δ
ρ0
 
 
 
Sample 
concentration 
(mg/mL) 
 
0.5 
(1) 
 
0.5  
(2) 
 
0.5  
(3) 
 
1.0  
(1) 
 
1.0 
(2) 
 
1.0 
(3) 
 
Mw (kDa) - from 
M* 
 
 
45.2 
 
45.4 
 
45.1 
 
44.1 
 
43.6 
 
43.9 
Mw (kDa) - from 
hinge point 
45.7 45.6 45.5 44.9 44.8 44.7 
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the hydration δ. Using these values and BIOMOLS2 a Perrin value of 1.091 
was obtained. This value was compared to the value obtained by Harding 
(1981) who obtained a slightly lower value of 1.033.  
The Perrin values were then inserted into ELLIPS1 and the axial ratios were 
obtained, Figure 3.4 shows the results of the analysis.  
   
 
Figure 3.5: Prolate models of ovalbumin with axial ratios. (A) 
Shape obtained from Harding (1981) study. (B) Shape determined 
from results of this investigation. 
Figure (3.4, A) shows the structure obtained from Harding (1981) which 
shows a prolate model with an axial ratio of 1.85:1. The shape shown in 
(3.4, B) shows a similar shape in that a prolate structure is indicated by 
the data, however the axial ratio is larger (2.7:1). 
As stated the Perrin function is derived using several parameters including 
the frictional ratio, this is obtained using data including the sedimentation 
coefficient. The result of the investigation showed that ovalbumin had an 
s value of ~3.2 S, whereas the study by Harding (1981) showed a 
sedimentation coefficient value of 3.38 S for ovalbumin. Therefore the 
differences in sedimentation coefficients will yield different frictional ratios 
which will affect the Perrin value, thus leading to different axial ratios.  
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The sedimentation coefficient obtained from this study was shown to have 
been impacted by the presence of partially degraded ovalbumin and 
dimeric ovalbumin, therefore the difference in value to Harding (1981) can 
be attributed to this. Had the sample not contained these contaminants 
the resulting axial ratio would have been closer to the 1.9:1 ratio. 
 
 
3.4 Conclusion 
 
The characterisation of ovalbumin involved the use of viscometry, density 
measurements, sedimentation velocity and sedimentation equilibrium 
measurements in order to determine the hydrodynamic properties of 
ovalbumin.  
The analysis methods showed that ovalbumin had an intrinsic viscosity of 
approximately 4.9mL/g which was higher than previous studies had 
indicated, however this was attributed to the presence of lower and higher 
molecular weight contaminants present. 
The sedimentation velocity g(s) data showed a large average peak at 3.2S, 
however there was an indication of extra material being present. The c(s) 
distribution indicated the main peak again at 3.2 S for monomeric 
ovalbumin, however there were also a peaks at both 1.5 S and 4.5 S which 
were indicative of degraded and dimeric ovalbumin respectively.   
Finally the sedimentation equilibrium data showed that the molecular 
weight of ovalbumin at a concentration of 0.5mg/mL was approximately 
45kDa, which corresponds to the actual molecular weight of ovalbumin.  
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4 Evidence of Vancomycin dimerisation and 
interactions with mucin 
 
4.1   Introduction 
Glycopeptides are a type of glycan with generally lower molecular weights 
that glycoproteins such as ovalbumin, glycopeptide antibiotics against 
serious diseases are like this. In essence, they are similar to glycoproteins 
composed of amino acids with glycans covalently bonded, however they 
are often much smaller; being composed of several amino acids bound 
frequently to oligosaccharide residues (Reynolds, 1989). 
Vancomycin is a antibiotic glycopeptide that is used to treat gram-positive 
bacterial infections, such as methicillin-resistant Staphylococcus aureus 
(MRSA) and Enterococcus species (Small et al., 1990). It is often a ‘last 
resort’ treatment due to the its potency and adverse side effects such as 
loss of hearing and possible kidney failure. The emergence of MRSA has 
led to vancomycin becoming administered more as a treatment. This 
increase in administration has led to the discovery of vancomycin-resistant 
cases (Gardete & Tomasz, 2014).  
Vancomycin is a small glycopeptide with a molecular weight of 1449Da, it 
is a member of the heptapeptide glycopeptide family as it is composed of 
seven modified amino acids joined to the vancosamine-glucose 
disaccharide (Jia et al., 2013). Figure 4.1 shows the structure of 
vancomycin with the seven amino acids highlighted and numbered; (1) N-
methyl-D-leucine, (2 & 6) m-chloro-β-hydroxy-D-tyrosine, (3) asparagine, 
(4) D-phenyl glycine, (5) p-hydroxy-D-phenylglycine and (7) m,m-
dihydroxy-L-phenylglycine. 
The glycan residue of vancomycin, vancosamine-glucose, is attached to 
the main peptide backbone through O-linked glycosidic bonds (Barna & 
Williams, 1984). The O-linkages are different to N-linkages seen in earlier 
in ovalbumin. Here, the oxygen of the glycosidic bond remains and is not 
replaced as for N-linkages.  
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Figure 4.1: Structure of vancomycin with numbered residues, see 
above. The disaccharide subunit is bound to residue 4 (purple) 
(Loll et al., 1998). 
 
The antibiotic mechanism through which vancomycin works is by binding 
to peptidoglycan precursor molecule on bacterial cell walls. This binding 
inhibits further synthesis of peptidoglycan resulting in a weak cell wall that 
can eventually burst as the bacteria grows (Yim et al., 2014).  
The terminal end of the peptidoglycan precursor consists of a D-alanyl-D-
alanine (D-Ala-D-Ala) residue, this D-Ala-D-Ala groups forms several 
hydrogen bonds with the vancomycin. The binding of vancomycin to the 
D-Ala-D-Ala results in an inhibition of transpeptidation and 
transglycosylation of the peptidoglycan precursor, reducing the levels of 
cross-linking between the peptidoglycan resulting in weak, less rigid cell 
wall (Nieto & Perkins, (1971a), Binda et al., (2014) & Williams et al., 
(1999). The binding of vancomycin to the D-Ala-D-Ala residues has been 
reported to occur as a dimer, whereby the binding of dimeric vancomycin 
to one residue increases the chance of vancomycin binding to another D-
Ala-D-Ala residue (Loll et al., 1998). However, these studies have looked 
at the dimerisation of vancomycin in the presence of the D-Ala-D-Ala 
peptidoglycan residues or similar structure. The first part of this 
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investigation explored the dimerisation of vancomycin in the absence of a 
possible ligands in several different buffer conditions, including a medical 
buffer. Using SE analysis the dissociation constant of dimeric vancomycin 
was determined. The results were compared to previous studies which 
determined the values in presence of the ligand. SV analysis of vancomycin 
is not possible owing to the low molecular weight of vancomycin. This 
would involve rotor speeds in excess of 50,000rpm which are not practical 
or safe with the equipment available. 
 
The second part of this study investigated the possible interaction of 
vancomycin with gastric mucins (GM). 
As stated, vancomycin is an effective antibiotic that’s use is minimised in 
order to reduce antibiotic resistance and possible harmful side effects. The 
normal administration procedure is to inject a solution of vancomycin at a 
concentration of between 2.5 - 5.0 mg/mL in a 0.9% NaCl solution 
intravenously. The reasoning being to obtain an entry time of the 
vancomycin at approximately 10mg/min (van Hal et al., 2013). This 
method is preferred to oral administration as the absorption of vancomycin 
within the intestine is poor, resulting in administrations of roughly 125mg 
four times a day. It has been reported that adverse side effects such as 
indigestion often occurs (Cataldo et al., 2012). The reason why 
vancomycin is poorly absorbed is not fully understood, therefore tin order 
to overcome this issue orally administered vancomycin must be taken 3 - 
4 times a day at in 500mg doses (Rybak et al., 2009).  
In cases where vancomycin is orally administered vancomycin enters the 
gastrointestinal (GI) tract, where it comes into contact with many different 
macromolecules. The resulting interactions with these macromolecules 
may result in the poor absorption of the vancomycin. One of the most 
common macromolecules that vancomycin is likely to interact with are 
gastric mucins (GM). They are abundant within the GI tract due to the 
lubrication and mucoadhesive properties (Gillis et al., 2013). Gastric 
mucins are large glycoproteins with very high levels of glycosylation, their 
molecular weights range commonly between 500kDa – 20MDa. The protein 
backbone of mucin typically makes up approximately 20% of the molar 
mass while the remainder (~80%) is normally representative of the 
attached glycans (Bansil & Turner, 2006). Due to the high levels of 
38 
 
glycosylation mucins adhere to most molecules within the GI tract through 
hydrogen bonds, hydrophobic and hydrophilic interactions (Harding et al., 
1999).  
On this basis this investigation looked at the interaction between gastric 
mucin, specifically porcine gastric mucin (PGM) from pigs as it is similar to 
the human homolog (HGM) and often used as a model for HGM (Kararli, 
1995). Using SV analysis the study will determine whether vancomycin 
interacts with PGM and, if so, what implications this would have on the oral 
administration of vancomycin.  
 
4.1.1.1 Aims of the Investigation 
 
This investigation has two main aims. Firstly to look at the dimerisation of 
vancomycin in the absence of a ligand, and to determine the resulting 
dissociation constant from SE analysis. The second aim is an interaction 
study between vancomycin and PGM to determine if this could be a 
possible reason for the low absorption of vancomycin through oral 
administration. 
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4.2   Materials and Methods 
 
4.2.1   Materials 
Several 1.0L buffers were prepared that consisted of different conditions; 
(A) 10mM HEPES buffer (pH 7.9), (B) 10mM HEPES buffer & 100mM NaCl 
(pH 7.9), (C) 10mM HEPES buffer & 100mM NaCl & 20% glycerol (pH 7.9) 
and (D) 0.9% NaCl in water. The latter buffer condition is the normal 
conditions in which vancomycin is administered, the concentration of 
vancomycin being between 2.5-5.0mg/mL.   
Two samples of vancomycin hydrochloride (powder) were supplied: one 
from Duchefa Biochemie, Haarlem, The Netherlands, the other from Sigma 
Aldrich, UK. They had a purity of 95% and 98%, respectively. The porcine 
gastric mucin type III (PGM) was supplied by Sigma Aldrich, UK. 
 
4.2.2   Sample Preparations 
Samples of vancomycin (Duchefa) were prepared in all four solvent 
conditions (A, B, C & D) to a stock concentration of 10.0 mg/mL, prepared 
by adding 15.0mg of vancomycin to 15.0 mL of each respective buffer 
type. Using each stock solution, a subsequent dilution series was created 
for each buffer condition. The dilutions consisted of concentrations of 5.00, 
2.50, 1.25 and 0.60 mg/mL vancomycin. Once prepared the samples were 
stored at a low temperature within a refrigerator to prolong the stability of 
the vancomycin.   
A separate Sigma vancomycin solution was prepared in 0.9% NaCl to a 
concentration of 50.0 mg/mL. Using the 50.0 mg/mL stock a dilution series 
was produced with concentration of; 40.0, 30.0, 24.0, 20.0, 12.0, 10.0 & 
6.0 mg/mL vancomycin. 
 
4.2.3   Vancomycin v¯ and concentration determination 
The conventional method for determining concentration is to use either 
spectrophotometry or refractometry, however in the case of vancomycin 
this was not possible as neither the extinction coefficient nor refractive 
increment were known. Therefore, in order to determine concentration 
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density measurements were carried out, as explained in section 2.1.1. In 
order to determine the concentration using equation (2.2), the v¯ of 
vancomycin had to be determined.  
The determination of the v¯ for vancomycin was calculated using work 
carried out by Durchschlag and Zipper (1994). This method allows the v¯ 
to be calculated based upon the structure of the molecule, in this case 
vancomycin. The method involves determining the partial molar volume 
(V𝒊), of given atoms or groups of atoms within a certain environment, 
within a given area of the molecule. Figure 4.2 shows the atoms that were 
taken into account. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2:  Structure of vancomycin with the different atomic 
environment highlighted. The number of each given atom is also 
indicated (top right). 
Using the Durchschlag and Zipper V𝒊 values for each atomic environment 
and the number of each atom in each environment, an overall weighted 
average V𝒊 for vancomycin was obtained. The overall V𝒊 was combined 
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with a correction value, calculated based upon the covolume, ring 
formation and ionisation of the vancomycin, to give a correct value. The 
main parameter of importance was the charge of vancomycin at pH 7.9. A 
study by Johnson & Yalkowsky (2006) showed that at pH 7.9 the charge 
on vancomycin was +1. 
Using these values the v¯ of vancomycin could be calculated using Equation 
(4.1).    
 
(4.1) 
 
Where ( v¯ ) is the partial specific volume (mL/g), (V𝒊) is the corrected 
partial molar volume of vancomycin (979.20 mL/mol) and (M) is the molar 
mass of vancomycin (1449.25 g/mol). Using equation (4.1) the v¯ for 
vancomycin was determined to be 0.67 mL/g.  
 
Once the v¯ was determined the concentration of the stock solutions could 
be calulated. For each solvent condition an equal amount of vancomycin 
was weighed out each time, therefore the concentration of one buffer 
(HEPES alone) was calculated as it would be representative of all 
conditions. The method outlined in section 2.1.2 was adopted with three 
density readings taken for both the solvent, the stock and first dilution with 
the results recorded in Table 4.1.  
 
4.2.4   Viscosity Measurements 
Viscosity and density measurements were recorded for each of the 
concentrations derived from the 50.0mg/mL dilution series in 0.9% NaCl. 
Density measurements were carried out in the same way as in 2.1.2 using 
the Anton Paar DMA5000 oscillating capillary meter to determine the 
density correction ratio (ρ/ρ0).   
Viscosity measurements were conducted using the method outlined in 
2.1.4, whereby 2.0 mL of a given concentration was placed into the U-tube 
and placed into the water bath at 20.0°C. The samples were then pumped 
up to the measuring reservoir and allowed to flow back down, with the flow 
times recorded in Table 4.2.  
v¯ = 
v¯𝒊
M
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4.2.5   Sedimentation Equilibrium of vancomycin 
SE runs were carried out using the Beckman XL-I AUC using 12mm 
aluminium cases and epoxy centrepiece cells. A total of four runs were 
carried out, with each solvent conditions being used per run. 
The samples were loaded into the cells with 0.1mL of sample placed into 
one sector and 0.1mL of buffer placed in the other sector. The cells were 
then placed into the 8 hole Ti rotor and placed into the AUC set at 7.0°C, 
fringe adjustment was made at 3000 rpm after which a rotor speed of 
47,500 rpm was applied. The cells were centrifuged at this speed for three 
days with Rayleigh interference optics taking readings every hour. 
 
4.2.6   Vancomycin and mucin sample preparation 
A stock solution of 10mL PGM at 5.0mg/mL was prepared using 0.9% NaCl. 
The solution was filtered using a Whatman Puradisc 30 cellulose acetate 
syringe filter with a 0.45μm cut off. The sample final concentration was 
then checked using the refractometer, with a dn/dc value of 0.165 mL/g 
being used in the calculations (Jumel et al., 1996). Using the concentration 
determined from the refractometer the stock solution was diluted down to 
4.0 mg/mL. A stock solution of 5mL vancomycin (Sigma Aldrich) with a 
concentration of 25 mg/mL was prepared in a buffer of 0.9% NaCl. Using 
both stock solutions a 1:1 dilution was made by combing equal volumes of 
the vancomycin and PGM together. This resulted in a solution composed 
of vancomycin and PGM at concentrations of 12.5 and 2.0 mg/mL 
respectively.  
In addition to this, a separate study looked at lower concentrations of 
vancomycin being added to PGM. 25.0 mg/mL stock solution was diluted 
10-fold twice, yielding concentrations of 2.50 and 0.25 mg/mL. When 
combined with an equal volume of PGM, final concentrations were 1.25 
and 0.125 mg/mL. 
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4.2.7   Sedimentation Velocity 
SV runs were carried out using the Beckman XL-I AUC, using 12mm 
aluminium epoxy centrepiece cells. Data analysis was carried out using 
SEDFIT(15b), parameter values of 1.0032 g/mL and 0.64 mL/g were used 
for buffer density and v¯ respectively. 
The samples were loaded into the XLI cells. 0.4 mL of the 0.9% NaCl buffer 
was injected into one sector of each cell and 0.4 mL of the sample was 
injected into the other sector. Five cells were used, 3 contained a solution 
of 12.5 mg/mL vancomycin with 2.0 mg/mL PGM, 1 contained 2.0 mg/mL 
mucin alone and the last cell contained just water. The cells were then 
placed into an 8 hole rotor set at 20.0°C, with a speed of 3000 rpm applied 
to adjust the fringes. Measurements were made at a rotor speed of 30,000 
rpm with Rayleigh interference optics for 12 hours, with scans taken every 
two minutes for a total of 500 scans. After the run was finished the cells 
were removed and examined. The examination revealed a thick layer of 
sedimented molecules. Analysis of the results on SEDFIT found that there 
was no sedimenting molecules present in the sample containing both PGM 
and vancomycin. It was hypothesised that these molecules sedimented 
immediately at the high speed. A further experiment was conducted 
whereby the samples were centrifuged at a much lower rotor speed of 
3000 rpm at 20.0°C for 12 hours with Rayleigh interference optics being 
used every 2 minutes.  
An additional SV run was carried out on the 12.5 mg/mL and diluted 
vancomycin solutions (1.25 & 0.125 mg/mL) with PGM added. The samples 
were placed separately into three XLI cells, with a reference sample of 
0.9% NaCl also added. The samples were placed into the XL-I centrifuge 
at a temperature of 20.0°C. A rotor speed of 3000 rpm was applied and 
interference optics took readings every two minutes for five hours. After 
this period the rotor speed was increased to 30,000 rpm for 12 hours, 
again with interference readings every two minutes. The reason for the 
increase was to determine if there was any non-aggregated mucin present. 
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4.3 Results and Discussion 
 
4.3.1   Concentration measurements 
The results of the density measurements for the 10 mg/mL stock 
vancomycin and the first dilution (5 mg/mL), showed that the nominal 
concentrations were very close to the actual concentrations (refer to table 
4.1). Using Equation (2.2) and a v¯ value of 0.67 mL/g the concentration 
of the stock solution was calculated to be 9.8 mg/mL and the first dilution 
was 4.9 mg/mL.  
Table 4.1: Determination of actual concentration from density 
measurements for 10.0 & 5.0 mg/mL vancomycin solutions at 
20.0°C. 
The concentrations indicated from the density measurements show that 
actual and nominal values are accurate to one another. The slightly lower 
values from the actual concentration can be attributed to the hydration of 
the sample.  
 
Due to the closeness of the nominal concentration to the actual 
concentration it can be reasonably assumed that the rest of the 
vancomycin buffer conditions have the same concentrations, as they were 
all made using the same weight of vancomycin. The determination of an 
accurate concentration is important for AUC analysis and in the calculation 
of the dissociation constants, as the concentration can have a large impact. 
Nominal 
concentration 
(mg/mL) 
Average Density 
(g/mL) 
Actual 
concentration 
(mg/mL) 
Actual 
concentration 
(g/mL) 
 
10.0 
 
1.002440  
 
9.8 
 
0.0098 
 
5.0 
 
1.000831 
 
4.9 
 
0.0049 
 
solvent 
 
 
0.9992 
 
- 
 
- 
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4.3.2   Viscosity measurements 
Density and viscosity measurements were made for all the vancomycin 
dilutions made from the 50.0 mg/mL 0.9% NaCl "medical" solvent.  
Solution density measurements were made in each case to determine the 
actual concentration and to correct the viscosity values due to the high 
concentration. Table 4.2 shows the density readings and the density 
correction ratio (ρ/ρ0) along with the actual concentration of each dilution 
determined using equation (2.2).  
Table 4.2: Density measurements at 20.0°C for each nominal 
dilution with the density correction (ρ/ρ0) and actual 
concentration calculated. 
The results shown in Table 4.2 show that the nominal concentrations are 
close to actual concentrations, they are within the range of ~3% similar to 
the results shown in 4.3.1. As stated earlier this slight decrease in actual 
concentration can be accounted for through the hydration of the 
vancomycin. The values for ρ/ρ0 are all above 1.0 which indicates that all 
the dilutions have a greater density than the buffer and as a result will 
determine a more accurate intrinsic viscosity value.  
Nominal 
concentration 
(mg/mL) 
Average Density 
(g/mL) 
ρ/ρ0 Actual 
concentration 
(mg/mL) 
 
50 
 
1.02045 
 
1.01582 
 
48.6 
 
40 
 
1.01750 
 
1.01289 
 
39.6 
 
30 
 
1.01417 
 
1.00957 
 
29.4 
 
24 
 
1.01239 
 
1.00780 
 
23.9 
 
20 
 
1.01108 
 
1.00649 
 
19.9 
 
12 
 
1.00847 
 
1.00389 
 
11.9 
 
10 
 
1.00779 
 
1.00322 
 
9.9 
 
6 
 
1.00648 
 
1.00192 
 
5.9 
 
0.9% NaCl 
 
1.00456 
 
 
- 
 
- 
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The viscosity of vancomycin was determined using the flow times of the 
vancomycin dilutions through an Ostwald capillary viscometer. The results 
of the flow times were used to determine the relative viscosity using 
Equation (2.3), the density correction ratios and actual concentrations in 
Table 4.2. Using the relative viscosity the subsequent reduced and inherent 
viscosities were calculated using Equations (2.4 & 2.5) respectively. The 
values for all three viscosities can be seen in Table 4.3 along with the 
average flow times. 
Table 4.3: Average flow times at 20.0°C for each concentration 
along with the subsequent relative, reduced and inherent 
viscosities. 
The results of the reduced and inherent viscosities in Table 4.3 show a 
general decrease as the concentration reduces. Using these values the 
intrinsic viscosity of vancomycin can be determined by plotting the results 
against their respective concentrations, as seen in Figure 4.3.  
Nominal 
concentration 
(g/mL) 
Average flow 
time (s) 
Relative 
viscosity, ηr  
Reduced 
viscosity, ηred 
(mL/g) 
Inherent 
viscosity, ηinh 
(mL/g) 
 
0.050 
 
109.53 
 
1.180 
 
3.709 
 
3.410 
 
0.040 
 
105.61 
 
1.135 
 
3.404 
 
3.193 
 
0.030 
 
102.63 
 
1.099 
 
3.370 
 
3.213 
 
0.024 
 
100.41 
 
1.074 
 
3.064 
 
2.957 
 
0.020 
 
99.41 
 
1.061 
 
3.076 
 
2.985 
 
0.012 
 
97.34 
 
1.037 
 
3.058 
 
3.003 
 
0.010 
 
96.43 
 
1.026 
 
2.651 
 
2.617 
 
0.006 
 
95.52 
 
1.015 
 
2.576 
 
2.557 
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Figure 4.3:  Intrinsic viscosity determination of vancomycin 
through the extrapolation of the reduced and inherent viscosities 
to zero concentration, at 20.0°C. 
The plot shows the linear regression of the Huggins and Kraemer plots, 
both of which show a positive slope, to zero concentration. The y-intercept 
for both data series shows an intrinsic viscosity value of (2.6± 0.2) mL/g. 
With regard to both data series in the Figure 4.3, the data points at the 
lower concentrations (6, 10 & 12 g/mL) have a large impact on determining 
the final [η] value. However a limitation of this is that the impact of error, 
through noise, increases at these concentrations effecting the final [η]. 
The data points in Figure 4 for the lower concentrations do not show large 
degrees of variation, meaning that the resulting y-intercept of 2.6 mL/g 
can be taken as reliable for both data series.     
The small [η] value of 2.6 mL/g for vancomycin is to be expected owing to 
its low molecular weight and small size. Low molecular weight globular 
proteins also tend to have low [η] ranging between 2.5-3.5 mL/g (Tanford, 
1961). 
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4.3.3   Sedimentation Equilibrium 
 
Vancomycin sedimentation equilibrium data for all dilutions of each buffer 
condition were analysed using SEDFIT-MSTAR. A baseline was found, data 
noise was removed by subtracting the average of the first 5 scans from 
the average of the last 5 scans (2.3.1.2), this was used to aid in 
determining the concentration at the meniscus for each solution. Similar 
to the results in 3.3.4, the baseline corrected data was used to yield plots 
showing; ln(c) vs r2, M* vs r and MW,app(r) vs c(r) as well as the 
concentration as a function of fringe units against radius. Using the data 
from the M* and Mw,app(r) plots the M* and hinge point molecular weights 
were found, Table 4.4 gives the values of both M* and hinge points 
determination for Mw for each solvent condition. 
 
Table 4.4: Molar mass estimations of vancomycin in the presence 
of all buffer conditions, showing the M* and hinge point 
evaluations of Mw. 
The results of the SEDFIT-MSTAR analysis shown in Table 4.4 show that 
as the vancomycin concentration increases so too does the weight average 
molar mass. 
  
 
HEPES Only 
 
HEPES + NaCl 
 
HEPES + NaCl 
+ Glycerol 
 
Water and NaCl 
 
conc 
(mg/ml) 
M* 
(kDa) 
Hinge 
(kDa) 
M* 
(kDa) 
Hinge 
(kDa) 
M* 
(kDa) 
Hinge 
(kDa) 
M* 
(kDa) 
Hinge 
(kDa) 
 
10 2.90 2.83 3.40 3.34 3.10 3.02 3.50 3.29 
 
 
5 2.70 2.62 2.70 2.54 2.60 2.64 3.00 2.86 
 
 
2.5 2.70 2.85 2.70 2.64 2.80 2.76 2.80 2.68 
 
 
1.25 - - 2.50 2.46 2.10 2.08 2.20 2.20 
 
 
0.6 
 
2.10 
 
2.15 
 
2.50 
 
2.51 
 
1.90 
 
1.90 
 
1.60 
 
1.62 
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The molecular weight of monomeric vancomycin is 1449 Da, therefore 
dimeric vancomycin will have a molecular weight of 2898 Da. The results 
in Table 4.4 show that at higher concentrations the vancomycin is in its 
dimeric form. This is suggested by the weight average molar mass being 
approximately 3000 Da. Although the higher concentrations indicate the 
presence of dimeric vancomycin, a degree of error is attributed to the 
values (±~10%). The error in these values is attributed to the optical 
systems, radial calibration, rotor speed and consistency calibration and 
temperature equilibrium of the AUC, the construction and state of the cells, 
as well as the concentration determination through SEDFIT-MSTAR. In 
addition the low molecular weight of vancomycin contributes to the error 
in these parameters thus leading to a ±10% error. With the error taken 
into account the molecular weights still indicate the presence of dimeric 
vancomycin.  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Changes of weight average molar mass of vancomycin 
with concentration. M* values (closed signals) and hinge point 
values (open symbols). Squares: HEPES alone. Circles: HEPES + 
NaCl. Up triangles: HEPES + NaCl + glycerol. Down triangles: Water 
+ 0.9% NaCl. 
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The MW,app(r) vs c(r) distributions for each concentration of a given solvent, 
used to determine the weight average molar masses by M* and hinge point 
analysis shown in Figure 4.4, were combined within Figure 4.5 to give an 
overall concentration distribution. The plot shows the weight average 
molar mass of the local concentration at a given radius, c(r), for each 
buffer condition; (A) 100mM HEPES, (B) 100mMHEPES + 100mM NaCl, (C) 
100mM HEPES + 100mM NaCl + 20% Glycerol and (D) water + 0.9% NaCl. 
Figure 4.5: Sedimentation equilibrium plots (MW,app(r) vs c(r)) of 
each concentration (A-D) overlaid for each solvent condition. (red) 
10mg/mL, (orange) 5mg/mL, (green) 2.5mg/mL, (blue) 
1.25mg/mL and (purple) 0.6mg/mL. 
The distributions shown in Figure 4.5 concur with the results seen in both 
Table 4.4 and Figure 4.4. All four plots show a molecular weight of ~1.5kDa 
at low concentration indicating the presence of monomeric vancomycin, 
however as the concentration increases the molecular weight increases 
and plateaus of at ~3kDa which suggests that the vancomycin is in its 
dimeric form. Both Figures 4.4 and 4.5 show that at a concentration of 
approximately 5mg/mL all of the vancomycin is in its dimeric form.  
The distributions within Figure 4.5 show evidence that the dimerisation of 
vancomycin is reversible. A study by Roark & Yphantis (1969) showed that 
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sedimentation equilibrium profiles, of a given concentration range, of a 
fully reversible system should overlay each other. The profiles in Figure 
4.5 for each buffer condition show this overlaying, thus indicating that the 
dimer formation of vancomycin is fully reversible. Assuming that the 
dimerisation is reversible both the association and dissociation constants 
can be determined. 
 
4.3.4 Determining the Association and Dissociation constants 
As stated above the results shown in Figure 4.5 show that the dimerisation 
of vancomycin is reversible. Using the data the strength of the association 
can be calculated using three parameters are defined; k2 (association 
constant), K2 (molar association constant) and Kd the molar dissociation 
constant (1/K2). 
Using Equation III-66 of Kim et al. (1977), shown in Equation 4.2, the Y(c) 
values as a function of concentration for each of the 4 solvent conditions 
can be determined:  
 
(4.2) 
 
where M1 is the monomer molar mass of vancomycin (1449 Da) and Mw(c) 
is the molar mass determined by SE analysis for each loading 
concentration, c. By subsequently plotting the Y(c) of each buffer 
concentration against their respective concentration, then plotting a linear 
line yields the k2 value. Figure 4.6 shows the Y(c) plots for concentration 
0.6, 1.25 & 2.5 mg/mL as it is at these concentrations where the 
vancomycin is dimerising.  
Y(c)= 
M1(Mw(c)-M1)
((2M1-Mw(c))
2
=k2.c 
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Using the slope (k2) values the K2 values can be determined by multiplying 
the k2 value by the vancomycin monomer molar mass (1449). The Kd is 
the inverse of this (i.e. 1/K2). Table 4.5 shows the values of each 
parameter. 
 
From the data provided in Table 4.5 it can be seen the Kd values of each 
buffer condition are relatively low, ranging between 30 - 60μM. This is an 
indication that the dimerisation of the vancomycin monomers is relatively 
weak. A study by Linsdell et al., (1996) obtained a Kd value of 250μM, 
which although a larger value (the precise details of the evaluation method 
is not described) than the obtained from this investigation (hence weaker 
interactions) all indicates that there is a weak interaction. In addition to 
this both this investigation and the study by Linsdell showed a similar error 
of ~20% in the Kd values. As both results in each investigation support 
each other it can be said that the dimerisation of vancomycin is a weak 
interaction.  
 
Solvent k2 (mL/g) K2 (M-1) Kd (μM) 
 
10mM HEPES 
 
18400 
±2000 
 
 
27600 
±3000 
 
35 
±5 
10mM HEPES + 100mM 
NaCl 
13100 
±2000 
 
20000 
±3000 
50 
±10 
10mM HEPES + 100mM 
NaCl + 20% Glycerol 
14500 
±3000 
22000 
±4000 
45 
±10 
 
0.9% (w/v) NaCl 
 
14400 
±3000 
 
21000 
±4000 
 
50 
±10 
 
Table 4. 5: k2, K2 & Kd values for each buffer concentration. 
53 
 
Figure 4.6: Y(c) plots of each solvent conditions at concentrations 
of 0.60, 1.25 & 2.50 mg/mL: (a) HEPES alone, (b) HEPES + NaCl, 
(c) HEPES + NaCl + glycerol, and (d) 0.9% NaCl. The slopes of each 
plot yield the k2 values. 
 
 
4.3.5 Vancomycin and mucin interaction SV analysis 
The sedimentation velocity data of the interaction studies between 
vancomycin and PGM were analysed using SEDFIT. This work was done in 
conjunction with Hayley Coupe. 
The result of the first SV runs between 12.5 mg/mL and 2.0 mg/mL PGM 
at 3000 rpm and 2.0 mg/mL PGM alone can be seen in Figure 4.7. The 
bottom distribution shows two peaks, a narrow peak at ~2S and a broader 
peak at ~11S after being centrifuged at 30,000 rpm. The narrow 2S peak 
is attributed to lower molecular weight contaminants. The main peak at 
~11S is indicative of the sedimentation coefficient of PGM (Bansil & Turner, 
2006). The peak is broad which reflects polydispersity within the solution 
due to the glycosylation of PGM.  
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Figure 4.7: Sedimentation velocity ls-g*(s) distributions of (Top) 
12.5 mg/mL vancomycin and 2.0 mg/mL PGM (x3 repeats) 
3000rpm, (Bottom) 2.0 mg/mL PGM alone 30,000 rpm. 
The top plot shows the distribution of the SV runs involving the mixtures 
of 12.5 mg/mL vancomycin and 2.0 mg/mL PGM run at 3000 rpm. The 
distribution indicates that the mass aggregation of the PGM has occurred 
as the value has increased from 11 S (monomer) to 1100 S, this suggests 
that vancomycin causes the mass aggregation of PGM. The results also 
show that aggregation occurs at a very fast rate, as using just the first 50 
scans (1.5hrs) yields the same result as the use of all scans (Figure 4.7).  
The formation of the large PGM/vancomycin complex also explains the 
presence of the thick sedimented layer at the bottom of the cells. 
The results of the interaction study clearly showed that vancomycin 
interacts with PGM and causes mass aggregation, however from this data 
it was unclear at what concentration vancomycin stop causing mass 
aggregation of PGM. 
Knowing that 12.5 mg/mL vancomycin causes PGM aggregation two 
additional dilutions were prepared to a concentration of 1.25 mg/mL (10x) 
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and 0.125 mg/mL (100x), both were added to 2.0 mg/mL PGM. As before 
the samples were spun at 3000 rpm for 5 hours, after which the SV data 
was analysed in SEDFIT (Figure 4.8).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: SV (3000 rpm) distribution of vancomycin + PGM at 
different concentrations of vancomycin (normalised); 12.5mg/mL 
(red) (dotted red line, previous study), 1.25 mg/mL (green) and 
0.125 mg/mL (blue). 
The distribution in Figure 4.8 has been normalised to the 12.5 mg/mL 
vancomycin run. The results clearly show that again the addition of 
12.5mg/mL vancomycin causes mass aggregation of the PGM, with a 
complex with a sedimentation coefficient of ~1200 S forming. By 
integrating this data it can be seen that the peak represents ~90% of the 
data, indicating most of the PGM has aggregated.  The first dilution of 
1.25mg/mL vancomycin shows that there is a dramatic decrease in PGM 
aggregation, as the complex has a lower s ~1000 S. Again integrating the 
data reveals the peak represents ~50% of the data. The distribution of the 
0.125 mg/mL vancomycin suggests minimal aggregation as the peak 
represents only ~12% of the data, suggesting an s of ~800S. It can 
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therefore be seen that as the concentration of vancomycin decreases by 
10 and 100 fold there is a dramatic decrease aggregation. 
In order to support the results seen in Figure 4.8 the sample was left to 
run in the centrifuge at an increased speed (30,000 rpm) for 12 hours, the 
purpose being to see if there was any non-aggregated PGM left within the 
cells. The results of the increased speed can be seen in Figure 4.9.  
Figure 4.9: SV (30,000 rpm) distribution of vancomycin + PGM at 
different concentrations of vancomycin (normalised); 12.5mg/mL 
(red), 1.25 mg/mL (green), 0.125 mg/mL (blue) and PGM alone 
(black). 
The distributions seen in Figure 4.9 support to a large extent the 
conclusions made based on Figure 4.8. From the distribution the 
sedimentation coefficient for PGM alone is shown to be ~11 S, this is the 
same value as indicated in Figure 4.7 (top). The results of the 0.125mg/mL 
vancomycin solution show the same at 30,000 rpm a very similar 
distribution is observed, this would suggest that this concentration results 
in little aggregation with predominantly monomeric PGM present. This is 
corroborated by the data in Figure 4.8, which showed that little to no PGM 
aggregates formed. With regard to the 1.25 mg/mL vancomycin sample 
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the data showed the formation of a single peak with a sedimentation 
coefficient of 11 S. The area under the curve in Figure 4.9 indicates that 
the monomeric PGM is at a much lower concentration, compared to the 
0.125 mg/mL sample, this suggests that more aggregation has occurred 
and supports the data shown in Figure 4.8 (green).  Finally the data of the 
12.5 mg/mL vancomycin shows a flat indicating that no monomeric PGM 
is present within the cell, supporting the claim in Figure 4.8 thus indicating 
that all of the PGM has aggregated.  
Overall the results seen in Figures 4.8 and 4.9 complement each other, 
the data suggests that between 0.125 mg/mL and 1.25 mg/mL 
vancomycin there is a critical concentration that vastly reduces the 
aggregation of PGM. These results are intriguing as vancomycin is orally 
administered four times a day at an average concentration of 125 mgs. 
The results of this study would suggest that at this concentration the 
vancomycin would cause mass aggregation of PGM, and as it is a homolog 
to the human gastric mucin (HGM) it can be assumed the same would 
occur in the human gut. Therefore it can be hypothesised that this mass 
aggregation, due to the high administrative concentrations, could be a 
large contributing factor for the poor absorption of vancomycin within the 
gut. It can also be suggested that the aggregates may also be the cause 
of indigestion, as the mucin not be properly lubricating the gut resulting in 
poor movement of the food within the gut.   
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4.3.6 Conclusion 
In conclusion the hydrodynamic characterisation yielded information 
regarding the viscosity, dimerisation and interactions of vancomycin.  
Viscometry analysis showed that the intrinsic viscosity of vancomycin was 
~2.55mL/g. The low intrinsic viscosity value likely a result of the low 
molecular weight. 
 
Sedimentation equilibrium analysis of vancomycin showed that in solution, 
and without the presence of a ligand, it forms dimers. Using M* and hinge 
point method evaluations for the weight average molar masses Mw and 
plots of the point weight average molar masses (Mw,app(r) vs c(r)) indicate 
that at low concentrations vancomycin is monomeric, however as 
concentrations increase to above 2.5 - 5.0 mg/mL it is apparent that 
vancomycin is dimeric. From the SE analysis the Kd values of the dimeric 
vancomycin were calculated to be between 30-60 μM in all solvent 
condition, indicating that the dimerisation of vancomycin is relatively 
weak.   
 
The interaction study between vancomycin and PGM showed that at a 
relatively low concentration vancomycin causes aggregation of PGM. The 
investigation showed that at high concentrations (12.5 mg/mL) 
vancomycin caused mass aggregation of PGM, with a sedimentation 
coefficient in excess of 1000 S. As the concentration was reduced the 
degree of aggregation also decreased until a concentration of 0.125mg/mL 
produced virtually no aggregates. The results indicate that a critical 
concentration between 1.250 - 0.125 mg/mL causes the formation of 
PGM/vancomycin aggregates. 
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5  Hydrodynamic characterisation of β-glucans 
 
5.1   Introduction 
β-glucans are a class of polysaccharide that are typically found in the cell 
walls of plant cereals, bacteria and fungi. The function of β-glucans within 
the cell wall are not entirely understood however recent studies have 
shown that β-glucans can form hydrogels within the cell wall, which may 
be used as a tethering point for other polysaccharides during cell growth 
(Kiemel et al., 2014).  This investigation looks at two types of cell wall β-
glucans, one sort of low molecular weight derived from a fungus 
(Macrolepiota procera (M.P)) and another of high molecualr weight from 
oat species. The β-glucan content between the two species differ, with oats 
containing approximately ~4% of the dry mass whereas mushrooms tend 
to contain ~8% of the dry mass (Hubner et al, (2010) & Rhee et al (2008)). 
 
Both mushroom and oat β-glucans are of increasing importance at the 
moment due to recent studies showing their impact on several health 
conditions. Mushroom derived β-glucans have been shown to have anti-
tumor properties, such as the reduction of tumours and increasing 
macrophage activity (Wang et al., 2005). Oat β-glucans however have 
been shown to reduce the levels of cholesterol within the blood, through 
binding to the cholesterol within the gut reducing absorption (Daou & 
Zhang, 2012). 
Generally β-glucans have a common backbone structure composed of a 
linear chain of D-glucose monomers joined by β,1-3 glycosidic bonds, 
however between species there are difference such as additional linkages 
and branching (Rahar et al., 2011). The structure of β-glucans derived 
from fungal species predominantly have a backbone formed of β,1-3 linked 
glucose monomers, however there are additional β,1-6 branch points at 
intermittent points (Zhu et al., 2015). In comparison β-glucans derived 
from oat species shows a β,1-3 and β,1-4 linkages, with tri and tetra β,1-
4 subunits forming linked by β,1-3 glycosidic bonds (Cui et al., 2000) . 
Figure 5.1 depicts the structures of the β-glucans derived from both 
mushroom and oat species. 
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β-glucans are characteristically large macromolecules with average 
molecular weights ranging between 20–900kDa depending on the source, 
with oat β-glucans having higher molecular weights (+200 kDa) than 
fungal β-glucans (Roubroeks et al, (2000) & Zhang et al., (2003)). The 
molecular weights of β-glucans can be affected by the extraction methods, 
as this can result in low or higher molecular weight extracts. Typically 
proteolytic enzymes are used to destroy hydrolytic enzymes that would 
degrade β-glucans within the cell wall, therefore extraction using this 
method often yields higher molecular weight β-glucans (Gamel et al., 
2014). Although the sizes (Mw) and linkages differ between species, 
generally β-glucans adopt a similar structure of a random coil (Varum et 
al., 1991). A result of both these aspects, size and conformation, is that 
many β-glucans having low solubilities as well as high viscosities. 
 
Figure 5.1: Structure of β-glucans derived from mushroom and oat 
species. (A) Mushroom β,1-3 backbone with β,1-6 branch point, 
(B) oat β,1-3 and β,1-4 linked backbone. (A) Laroche & Michaud 
(2007) and (B) Pillai et al. (2005). 
The solubility of oat β-glucans they are dependent upon the amount of 
tri/tetra subunits that are present within the β-glucans.  If the β-glucans 
consist of a similar subunit distribution then they are able to for aggregate 
together, thus reducing the solubility of the β-glucan, as they can for 
interactions between each chain. However, if there is not a consistent 
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subunit distribution then uniformity is vastly reduced inhibiting the 
formation of aggregates, thus increasing solubility (Burton et al., 2010). 
Generally the solubility of oat β-glucans in water is good however better 
with salts. The viscosity of oat β-glucans is generally very high, owing to 
the size and solubility. Typical viscosity values for oat β-glucans of an 
average molecular weight (200 kDa) are ~350 mL/g (Lazararidou et al., 
2003). Measurements of viscosity are often used to indicate the molecular 
weight of β-glucans.     
With regard to the solubility and viscosity of mushroom derived β-glucans, 
they are different from their oat counterparts. The solubility of mushroom 
β-glucans are generally poor this if often due to the structure of the 
molecule, however there is not a lot of evidence to show this. As seen in 
Figure 5.1 the β,1-3 backbone is flat linear, it has been suggested that the 
linear chain allows back-back interactions to form between β-glucan 
chains. In addition the branch points have been suggested to interact with 
branch chains on other β-glucans as well, resulting the formation of 
aggregates and thus reducing solubility (Wasser, 2011). Mushroom β-
glucans are virtually insoluble in water however more soluble in alkali 
solution, in addition high mixing temperatures are often applied to increase 
solubility further (Zhu et al., 2015).  
The viscosity of mushroom β-glucans is almost the polar opposite to oat 
β-glucans, in that these β-glucans have much lower intrinsic viscosities 
ranging in the 10’s not 100’s mL/g (Kimura et al., 2006). 
 
5.1.1   Aim of investigation 
The aim of the investigation is to characterise and compare the 
hydrodynamic properties of two different β-glucans obtained from 
mushroom and oat sources. The hydrodynamic characterisation involves: 
 Viscosity measurements to determine if there is a considerable 
difference between each species.  
 SV analysis to determine the sedimentation coefficient and 
heterogeneity of each β-glucan type.  
 SE analysis to estimate the weight average molar mass of the β-
glucan samples. 
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5.2   Materials and Methods 
 
5.2.1   Materials 
A 1L phosphate buffered saline (PBS) solution of pH 7.0 was prepared 
using 2.923g sodium chloride, 1.561g dihydrogen potassium 
orthophosphate and 4.595g sodium dihydrogen dodecahydrate, obtained 
from Sigma Aldrich, UK. A 2L 0.1M sodium nitrate (NaNO3) (Sigma Aldrich, 
UK) dialysis solution was produced. 
Two β-glucans were provided from different sources. The first β-glucan 
were derived from an unknown oat species provided by NOFIMA (Norway), 
they consisted of six samples (7-12) of the same β-glucan. The second β-
glucan can from the mushroom species Macrolepiota procera (M.P), the 
sample was provided by Dr Cleanthes Israilides, NAGREF, Lykovrysi, 
Greece. 
 
5.2.2   Mushroom (M.P) β-glucan sample preparation 
From the powdered sample of the M.P β-glucan a stock solution was 
prepared to a nominal concentration of 7.0 mg/mL in 40mL PBS buffer. 
Owing to the high difficulty of getting β-glucans into solution (Zhu et al., 
2015), the solution was heated to 90°C and left on a gentle stir for 5 hours. 
A large majority of the β-glucan was in solution however not fully, in order 
to remove the insoluble β-glucan material the sample was centrifuged at 
2000 rpm for five minutes to remove the large insoluble material. After 
centrifugation the supernatant was removed with the pellet placed into the 
fridge.  
The concentration of the supernatant was determined using the 
refractometer, with a dn/dc value of 0.146 mL/g (Li et al., 2006), this was 
revealed to be 6.4 mg/mL. Using the supernatant stock solution a dilution 
series was produced consisting of 5.0, 4.0, 3.0, 1.0, 0.5 and 0.3mg/mL β-
glucan in PBS. 
 
63 
 
5.2.3   Oat β-glucan sample preparation 
The samples of β-glucans from NOFIMA were supplied by Dr. S. Ballance 
in a solution of water with 0.02% sodium azide. The samples were said to 
contain possible low molecular weight contaminants, therefore the samples 
were dialysed. Dialysis was carried by placing 100mL of each β-glucan 
sample into a 40mm wide cellulose based dialysis tubing, with a molecular 
weight cut off of 12-14kDa. The samples were placed into 1L of NaNO3 and 
left for 6 hours after which the dialysed NaNO3 (dialysate) was removed 
and kept, an additional 1L of NaNO3 was added to the sample and left 
overnight. Once dialysis was complete the dialysate was removed and 
placed with the previous dialysate. The samples were removed from the 
dialysis tubing and placed into containers.  
 
Concentration estimates of the samples were provided by NOFIMA, 
obtained from enzymatic digestion of the β-glucans. However due to the 
dialysis the concentrations were determined again using the refractometer. 
The measurements were carried out as in 2.2.2, using a dn/dc value of 
0.146 mL/g (Li et al., 2006). The results from the refractometery were 
placed in Table 5.1 along with the enzyme digestion concentrations.  
 
5.2.4   Density and Viscosity measurements 
The density measurements for both β-glucan species were conducted in 
the same manner, using the method outlined in 2.1.2 with the Anton Paar 
DMA5000 density meter.  Density measurements for the mushroom β-
glucan samples were carried out on the higher concentration solutions, 
leaving out the 1.0, 0.5 & 0.3 mg/mL dilutions. The individual samples of 
oat β-glucan from NOFIMA were measured using the same method. 
Viscosity measurements were conducted using the method outlined in 
2.1.4, using an Ostwald U-tube viscometer and the Schott-Gerӓte AVS 400 
timing unit, recording the flow times. The flow time’s mushroom β-glucan 
samples were recorded at a temperature of 20.0°C. Likewise the same 
procedure was carried out for the oat β-glucan samples. The results were 
recorded in Table 5.2 along with the subsequent calculated viscosities.  
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5.2.5   Mushroom and Oat β-glucan SV analysis 
 
SV analysis was carried out using the Beckman XLI-AUC, using 12mm 
aluminium cases containing an epoxy centrepiece. Data analysis of the 
scans was carried out using SEDFIT producing both ls-g*(s) and c(s) 
distributions (refer to 2.3.1.1). 
  
Mushroom β-glucans 
The low concentration β-glucan samples of 1.0, 0.5 & 0.3mg/mL were 
analysed. Each concentration was inserted into one of three cells to a 
volume of 0.4mL, along with 0.4mL of the PBS buffer in the other 
corresponding sector. The cells were inserted into the 4 hole Ti rotor and 
placed into the AUC chamber set at 20.0°C. A rotor speed of 3000 rpm 
was applied to adjust the fringes, after which a speed of 50,000 rpm was 
used, with measurements made using Rayleigh interference optics. Scans 
were taken at 2 minute intervals until 500 scans were acquired. 
For analysis on SEDFIT a solvent density and v¯ of 1.0032 g/mL (measured 
by density meter) and 0.60 mL/g (Woodward et al., 1983) were used, 
respectfully. 
 
Oat β-glucans 
Each sample was loaded into one of six cells to a volume of 0.4mL with 
0.4mL of the dialysate buffer injected into the adjacent corresponding 
sector, a cell containing just water was also prepared. The cells were 
placed into the 8 hole Ti rotor and placed into the AUC, set at 20.0°C. A 
speed of 3000 rpm was applied to optimise the fringes, upon which a speed 
of 45,000 rpm was applied. Measurements were made using Rayleigh 
interference optics at 2 minute intervals until a total of 500 scans were 
acquired. For SEDFIT a v¯ of 0.6 mL/g and solvent density of 1.0039 g/mL 
were used.       
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5.2.6   Mushroom and Oat β-glucan SE analysis 
SE was carried out using the Beckman XLI-AUC, using the 20mm titanium 
centrepieces in aluminium cases. All SE data was analysed using SEDFIT-
MSTAR using the average of the last 5 scans minus the average of first 5 
scans (refer to 2.3.1.2). The parameters used in the SV analysis for both 
β-glucans were used again for SE analysis.  
 
Mushroom β-glucan 
The same three samples used in the SV analysis were used again. Of each 
sample 0.15mL was inserted into one of three cells, in addition 0.15mL of 
PBS buffer was injected into the adjacent sector. The samples were placed 
into the 4 hole Ti role and placed into the AUC, set at 20.0°C. The fringes 
were adjusted at 3000 rpm, with the speed increased 30,000 rpm 
thereafter. The samples were centrifuged for 72 hours, with measurements 
made using Rayleigh interference optics every 1 hour. Five scans were 
taken at the beginning and end of the run in addition.  
Oat β-glucan 
SE analysis of the NOFIMA β-glucans was carried out using the same six 
samples in the SV analysis. A sample volume of 0.15mL was inserted into 
each cell along with an equal volume of the dialysate buffer. The cells were 
loaded into a 8 hole Ti rotor and placed into the AUC, set at 20.0°C. A rotor 
speed of 3000 rpm was applied to adjust the fringes. Using estimated 
molecular weight from the SV analysis a rotor speed of 8000 rpm was 
selected to be applied to the samples. Measurements were made using 
Rayleigh interference optics, taking readings every 1 hour for 85 hours. 
Five scans were taken at the beginning and end of the run in addition. 
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5.3  Results and Discussion 
 
5.3.1   Mushroom β-glucan 
 
5.3.1.1 Mushroom β-glucan viscosity  
 
The flow times of the β-glucan concentrations, along with the density 
measurements, were used to determine the ηred and ηinh viscosities. 
Because of the low flow time increments compared to the solvent only the 
Solomon-Ciuta equation was applied at a single concentration, rather than 
a concentration extrapolation.   
Table 5.1: Relative, reduced, inherent viscosities and intrinsic 
viscosity of M.P mushroom β-glucans (20.0°C). 
A study by Kimura et al. (2006) on β-glucans derived from a yeast like 
fungus (Aureobasidium pullulans), showed that the β,1-3 (β,1-6 branched) 
linked β-glucans had a low intrinsic viscosity value and molecular weight 
(less than 100kDa). The results of the intrinsic viscosity measurements of 
this investigation suggest that a similar structured β-glucan is present 
within the M.P mushroom species. SE analysis examined later also 
supports this claim. 
 
 
  
 
Concentration 
(g/mL) 
ηr  
(mL/g) 
ηred 
 (mL/g) 
ηinh 
 (mL/g) 
[η] 
(mL/g) 
 
0.0064 
 
1.022 
 
3.424 
 
3.387 
 
3.413 
0.0050 1.016 3.176 3.152 3.183 
0.0040 1.012 2.938 2.921 2.988 
0.0030 1.009 2.823 2.811 2.991 
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5.3.1.2   Mushroom β-glucan SV and SE analysis 
 
The SV data for the M.P β-glucans was analysed using SEDFIT, in each 
concentration every second scan of the first 250 scans was analysed. The 
data was used to produce both g(s) and c(s) distributions for each species. 
The SE data analysis involved SEDFIT-MSTAR and the method outlined in 
2.3.1.2. 
5.3.1.2.1 SV analysis 
 
The SV results were used to produce a distribution plot, Figure 5.2, which 
shows the sedimentation coefficient of the M.P β-glucans derived from 
SEDFIT. Figure 5.2 shows two plots; (top) ls-g*(s) analysis and (bottom) 
c(s) analysis.  
Figure 5.2: SEDFIT SV analysis of M.P β-glucan concentration 
series, at a rotor speed of 50,000rpm. (Top) ls-g*(s) plot and 
(Bottom) c(s) analysis. 
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The g(s) distribution (top) indicates that the sedimentation coefficient of 
the β-glucans is approximately 1.4 S, through the integration of the data 
peaks within SEDFIT the same sedimentation coefficients were obtained. 
The results are intriguing as generally as concentration reduces the 
sedimentation coefficient increases, due to the reduction of non-ideality. 
The s values of M.P β-glucans do not show this trend instead showing very 
similar s values as the concentration decreases. In addition the data that 
produces the sedimentation peaks of each concentration constitutes 
approximately 85% of the total signal obtained from the cell, this leads to 
a suggestions that the β-glucans are relatively monodispersed.  
 
The c(s) plots (bottom) show a similar distribution, however 
characteristically of c(s) analysis there is an over sharpening of the peaks. 
This over sharpening has resulted in the formation of 2 peaks from the 1 
peak seen in the g(s) analysis, and in addition has formed some higher 
sedimentation coefficient peaks. The presence of two peaks, in close 
proximity to each other, would suggest that there is actually only one peak 
present. 
 
The low s values indicate that the β-glucans have a low molecular weight, 
using the c(M) algorithm within SEDFIT an estimated molecular weight of 
~10kDa was obtained for each sample. The indication of the same 
molecular weight in each concentration supports the assumption made 
from the g(s) plots that the samples are relatively monodispersed.  
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5.3.1.2.2 SE analysis 
 
SE analysis carried out by SEDFIT-MSTAR, yielded results for each M.P β-
glucan concentration. From the data four plots were found for each 
concentration; c(r) vs r, lnc(r) vs r2, M* vs r and Mw,app c(r) vs c(r). Figure 
5.3 shows the four distributions the 0.5mg/mL β-glucan, similar plots were 
produced for all concentrations. Using the data from SEDFIT-MSTAR for 
each cell the Mw determined from the M* and hinge point analysis 
methods, along with the polydispersity were recorded in Table 5.4. 
Figure 5.3: Molar mass analysis for 0.5mg/mL M.P β-glucan from 
SEDFIT-MSTAR: (A) Distribution of data along the radius of the 
cell, (B) log of concentration in the cell vs the square of the radial 
displacement, (C) M* analysis vs radius, (D) point average 
molecular weight. 
Using Figure 5.3, plot (B) shows the natural logarithm of the data against 
the square of the radius. From the plot it can be seen that the fitted data 
(red) overlays the raw data (black). The overlaying of both data sets, 
coupled with the lack of upwards or downwards bending of the data, 
suggests that there is little polydispersity within the cell. Table 5.2 shows 
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that similar data was obtained for all the concentrations, using the Mz data 
the polydispersity indexes of each concentration were ~1.0. The low 
polydispersity index values indicate that the M.P β-glucan samples are 
predominantly monodispersed, thus supporting the observations from the 
SV distributions.   
 
Plot (C) shows the M* analysis, this yields (from M*(r) extrapolated to the 
cell base) the weight average molar mass over the whole distribution, Mw. 
The data shows that the average molar mass, for this given concentration, 
is approximately 10.2 kDa. Similar M* derived molecular weights Mw were 
obtained for the other concentrations, Table 5.2. Plot (D) shows the local 
point average molecular weights Mw(r) plotted against loading 
concentration in the ultracentrifuge cell, c(r), the distribution supports the 
molecular weight determined from the M* analysis indicating a molecular 
weight of ~10.3 kDa. 
Table 5.2: Summary of weight averages of M.P β-glucans using M* 
and hinge point analysis, along with the polydispersity of the 
samples. 
 
 
 
Sample 
(mg/mL) 
 
0.3 
 
0.5 
 
1.0 
 
Mw (kDa) from 
M* 
 
10.0 
 
10.1 
 
10.3 
 
Mw (kDa) from 
hinge point 
 
10.1 
 
10.2 
 
10.3 
 
Mz 
 
10.1 
 
10.1 
 
 
10.4 
 
Polydispersity 
 
1.0 
 
1.0 
 
1.0 
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5.3.1.3 Shape estimation 
 
A study by Stahmann et al (1995) regarding single stranded β-glucans 
with β, 1-3, β,1-6 branches have been shown to have a persistence length 
of 300nm. The persistence length is a measure of how rigid a molecule is, 
the greater the value the more rigid a molecule is. Therefore assuming the 
M.P β-glucans are similar in structure they will also have a high rigidity, 
particularly as they are low molecular weight short-chain structures, which 
tend to have limited flexibility compared to larger linear structures in any 
case. Using this information and subsequent data from the SE run an 
estimation of the shape of the M.P β-glucans can be made based on 
ellipsoidal modelling. Using SEDFIT an estimation as to the frictional ratio 
of the β-glucans was shown to be ~1.8 in all three concentrations. Using 
this value along with the s (1.4S), v¯ (0.60 mL/g), molecular weight 
(10kDa) and an array of hydration values the Perrin function can be 
calculated, using BIOMOLS2. Using different hydration values; 0, 0.3, 1.0 
& 2.0g g-1, several Perrin function values were calculated. By using these 
Perrin values and inserting them into ELLIPS1 algorithm of Harding et al 
(2005), an estimation as to the shape of the mushroom β-glucans was 
made (Figure 5.4). 
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Figure 5.4: Prolate models of M.P β-glucans using different 
hydrations; (A) 0.0, (B) 0.3, (C) 1.0 & (D) 2.0 g water/ g of β-
glucan. 
β-glucans have varying degrees of hydration, therefore use a range of 
values it is possible to see the range of possible conformations that the β-
glucans may take on. As can be seen in all plots in Figure 5.4 the shapes 
indicate an extended prolate with axial ratios of; (A) 4:1, (B) 7:1, (C) 13:1 
and (D) 18:1. The lower hydration values are unlikely to be correct as 
polysaccharides often have a hydration greater than 1, therefore the latter 
shapes (C) and (D) are more likely to be representative of the true 
conformation, extended prolates.  
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5.3.2   Oat β-glucan 
 
5.3.2.1 Concentration determination 
 
After dialysing the samples overnight in NaNO3 the concentration of the 
resulting solutions was determined using the refractometer, the results are 
seen in Table 5.3. The concentrations were calculated using Equation 
(2.11), with a dn/dc value of 0.146 mL/g (Li et al., 2006) was used for the 
β-glucans. 
Table 5.3: M.P β-glucan concentration comparison between 
enzyme digestion and refractometry determination (after 
dialysis). 
 
The results show that the original concentrations, determined by enzyme 
digestion, are similar to the concentrations determined (after dialysis) by 
refractometry. For the purpose of this study the concentrations determined 
using the refractometer were used. These values were chosen over the 
enzyme digestion as this method is more reliable due to the possible 
changes in concentration after dialysis. 
 
 
Sample 
 
Enzyme digestion 
concentration (mg/mL) 
 
Dialysed concentration 
(Refractometry) (mg/mL) 
 
7 
 
1.03 
 
1.47 
 
8 
 
1.20 
 
1.47 
 
9 
 
1.15 
 
1.45 
 
10 
 
1.02 
 
1.41 
 
11 
 
1.24 
 
1.45 
 
12 
 
1.21 
 
1.43 
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5.3.2.2 Viscosity measurements 
 
Viscosity measurements were carried out to ultimately estimate the size 
of the β-glucans. 
The flow times of the oat β-glucan samples were vastly different from the 
mushroom β-glucans, the flow times ranged between 150 – 520 seconds. 
The reduced and inherent viscosities, determined from the flow times Table 
5.4, indicate that the size and shape of the β-glucans are large and varied 
between each sample. Although the different viscosities show a wide range 
the Solomon-Ciuta values (an average) indicate that the bulk of the 
viscosities lie within the range of 400 – 1000 mL/g, with sample 9 showing 
a value that is much higher (1600 mL/g). Figure 5.5 shows the results of 
all three viscosities of each sample. 
 
Table 5.4: Reduced and inherent viscosities of all six oat β-glucan 
samples, along with the Solomon-Ciuta intrinsic viscosity values 
(Temp= 20.0°C). 
 
 
 
Sample 
 
 
ηred (mL/g) 
 
ηinh (mL/g) 
Solomon-Ciuta 
[η] (mL/g) 
 
7 
 
590 
 
425 
 
474 
8 852 552 638 
9 3020 1160 1601 
10 1241 717 862 
11 904 578 671 
12 1872 911 1160 
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Although the samples yielded a range values they all indicate that the oat 
β-glucans have high intrinsic viscosities. Previous studies by Doublier et 
al. (1995) and Lazararidou et al. (2003) showed that a preparation of an 
oat β-glucan with an Mw of 250 kDa had an [η] of 383.0 mL/g. Using this 
as a platform, and the viscosities obtained from this investigation, it can 
be assumed that the samples also have high molecular weights. However 
the use of single concentration data points does not give a true 
representation of the actual intrinsic viscosities of the β-glucans, this is 
due to effects such as non-ideality being high. Owing to time constraints 
further analysis was not carried out on the viscosities. Further analysis 
using different concentrations will allow an extrapolation of zero 
concentration, yielding what is likely to be a lower intrinsic viscosity for 
each sample.  
Figure 5.5: ηred (black) and ηinh (red) data points of a single 
concentration of each oat β-glucan sample, with the resulting 
Solomon-Ciuta (green) values. The data points show the majority 
of values lie in range of 450 – 1000 mL/g. 
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In addition the viscosity measurements, are immensely larger than the 
viscosity measurements obtained for the M.P β-glucans. This is to be 
expected as previous studies suggests oat β-glucans have a much larger 
viscosity (Lazararidou et al., 2003). 
 
5.3.2.3 Oat β-glucan SV and SE analysis 
 
5.3.2.3.1 SV analysis 
The results of the viscosity measurements, Table 5.4, suggest that the size 
of the β-glucans is relatively large. Therefore it was expected that the 
sedimentation coefficients of the β-glucans would also be large. Using 
SEDFIT the SV data was analysed, producing both a g(s) and c(s) 
distributions seen in Figure 5.6. 
Figure 5.6: Sedimentation velocity ls-g*(s) analysis of all six 
NOFIMA β-glucan samples (S7-S12), at a rotor speed of 
45,000rpm. 
The distributions show that the sedimentation coefficients are not the same 
for each sample, however using the g(s) distribution the s values all lie 
within a range of 2.6–3.6 S.  
 
The g(s) analysis shows that a single peak for each sample is present, 
which is an indication of a unimodal system similar to the results of the 
M.P β-glucans. However the broadness of the peaks suggest very high 
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polydispersity.  A study by Woodward et al. (1983) showed that β,1-3 & 
β,1-4 linked β-glucans with molecular weights of 160 & 290 kDa had 
sedimentation coefficients of 3.5 & 4.5 S, respectively. The sedimentation 
values in that study are similar to the values obtained by this investigation, 
suggesting that the molecular weights of the oat β-glucans are 
approximately ~200 kDa. In order to confirm this hypothesis the use of SE 
data is required.  
 
5.3.2.3.2 SE analysis 
SE analysis of the oat β-glucans was carried out using SEDFIT-MSTAR, in 
which a baseline and loading concentration at the meniscus was 
determined for each sample. The analysis of the data produced four plots; 
c(r) vs r, lnc(r) vs r2, M* vs r and Mw,app(r) vs c(r). Figure 5.7 shows the 
four plots for Sample 7 (1.47 mg/mL). 
Figure 5.7: Molar mass analysis of oat β-glucan Sample 7 (1.5 
mg/mL). (A) c(r) vs r, (B) lnc(r) vs r2, (C) M* vs r & (D) Mw,app(r) 
vs c(r). Hinge point Mw is shown with dotted line. 
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Because of the relatively high concentrations used (1.5 mg/mL), all the 
values are only apparent values Mw,app, i.e. not corrected for non-ideality. 
These will differ from the true values which would normally be determined 
by extrapolating 1/Mw app vs c to zero concentration (see Harding, 2005). 
This was outside the scope of this MRes study and is the subject of further 
research. Nonetheless Mw,app values are shown for each sample for 
comparison purposes.  
Table 5.5: The results of all six samples with M* and hinge point 
molecular weight estimations for all Mw,app, along with the 
respective polydispersity indices. Shown also is their respective s 
and Solomon-Ciuta [η] values. 
These values are all apparent values obtained at a concentration of 
1.5mg/mL, and are included only for comparative purposes. Full 
extrapolations to zero concentration to correct for non-ideality is the 
subject to Further Work, beyond the scope of this MRes.  
 
  
 
 
 
Sample 
s, (S) Mw,app from M* 
analysis (kDa) 
Mw,app from 
hinge point 
(kDa) 
[η] 
 (mL/g) 
 
7 
 
2.7 
 
230 
 
240 
 
470 
 
8 
 
3.0 
 
350 
 
360 
 
640 
 
9 
 
3.5 
 
600 
 
700 
 
1600 
 
10 
 
3.3 
 
320 
 
330 
 
860 
 
11 
 
2.8 
 
310 
 
320 
 
670 
 
12 
 
3.0 
 
420 
 
400 
 
1160 
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5.4 Conclusion 
 
The investigation found that mushroom β-glucans derived from 
Macrolepiota procera were very low molecular weight with very low 
intrinsic viscosities. The viscosities were indicative of a small 
macromolecule that had both a low molecular weight and a compact 
structure.  
The results of the SV analysis showed a molecule that had a low 
sedimentation coefficient (~1.4S), again indicating a small size with a low 
molecular weight. In corroboration with these results, regarding the small 
size, was the SE analysis which indicated a molecular weight for the 
mushroom β-glucans of approximately 10kDa. Using both the viscosities 
and s values the conformations of the β-glucans were determined.  
The hydrodynamic characterisation of the oat β-glucans showed that these 
molecules were very different. The viscosity measurements showed that 
the oat β-glucans had extremely high viscosities, ranging between 400-
1000mL/g, vastly different from the mushroom β-glucans. The viscosities 
also indicated that the molecular weight and size of these β-glucans was 
much larger than the mushroom β-glucans. 
 
SV analysis showed that the oat β-glucans had a range of sedimentation 
coefficients (2.6-3.6S). These values were considerably larger than the 
mushroom β-glucans again indicating a higher molecular weight. Because 
of the time restrictions on the MRes, only the apparent molecular weights 
at a concentration of 1.5 mg/mL have been shown for comparative 
purposes. Nonetheless they show that oat β-glucans are much larger than 
they mushroom ones.  
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6 Concluding Remarks 
 
6.1 Ovalbumin 
The main aim of this part of the investigation was to learn and execute 
several hydrodynamic characterisation methods, including viscometry, 
density measurements and Analytical Ultracentrifuge techniques. The work 
carried out on ovalbumin, a previously well hydrodynamically 
characterised glycoprotein, allowed these techniques to be established. 
Sedimentation velocity analysis showed that the ovalbumin contained 
significant amounts of lower molecular weight and higher molecular 
materials, although the main component with a sedimentation coefficient 
(s20,w) value of 3.2S was present with a similar s to previously published 
values. However, both the ls-g*(s) and c(s) distributions showed the 
presence of lower and higher molecular weight contaminants. Even though 
the presence of contaminants were confirmed by SV analysis, the  weight 
average molar mass indicated from SE was the same as the actual value 
of 45kDa. 
 
Overall the intrinsic viscosity value of ovalbumin for this preparation was 
slightly higher than previous published values for monodispersed 
ovalbumin solutions, but this is consistent with what we see from 
sedimentation velocity analysis. This is also reflected in the slightly more 
elongated prediction for the shape of the molecule from ELLIPS1.  
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6.2 Vancomycin 
The investigation into vancomycin had two main aims; determine the 
possible dimerisation in the absence of a ligand and determine the 
subsequent Kd value, and to investigate the interactions between 
vancomycin and gastric mucin (PGM). The investigation used methods 
including viscometry, SV and SE. 
The first part of this investigation yielded information regarding the 
intrinsic viscosity of vancomycin, which was found to be ~2.55 mL/g. this 
value indicates a macromolecule with a small size, which is what 
vancomycin is (Mw 1449 Da).  
The main results of the investigation found that between and above a 
concentration range of 2.5 - 5.0 mg/mL vancomycin forms dimers, below 
this range and vancomycin is predominantly monomeric. The investigation 
found that the dimerisation is fully reversible, with subsequent Kd values 
ranging between 30 - 60μM in all buffer conditions.  
The second part of the investigation found that vancomycin causes mass 
aggregation of PGM above a concentration of 1.25 mg/mL. The results 
suggest that above this concentration vancomycin causes over 50% of a 
given PGM to aggregate, with almost all PGM forming aggregates at a 
concentration of 12.5 mg/mL. The results of the investigation suggest that 
the aggregates may be the reason for the poor absorption of vancomycin 
within the gut, therefore future work into this is needed to evaluate this 
conclusion. 
 
6.2.1 Future work 
The investigation into vancomycin yielded several important conclusion, 
the greatest being the aggregation of mucin through the addition of 
vancomycin. 
An immediate continuation of the investigation will be determine what the 
critical concentration of vancomycin is that causes significant aggregation 
of PGM. In addition to this is to see of these effects are observed in other 
buffers.  
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In conjunction to the use of AUC (SV) is the possible use of a disc 
centrifuge (CPS), which can also be used to determine the interaction 
between PGM and vancomycin. CPS will also yield information regarding 
the macromolecular radii of the aggregates which can be used to better 
understand the structure of the complex that forms. This would 
complement the data obtained from the SV analysis.  
An important continuation of this work would be to see if these effects are 
seen in other mucins, e.g. bovine submaxillary mucin (BSM) and human 
gastric mucin (HGM). The aim would be to replicate the results seen with 
PGM and vancomycin, thus supporting the conclusion made from this 
investigation.  
Using the findings of this investigation and future investigations using 
HGM, would be to investigate the binding mechanism between vancomycin 
and mucin using vancomycin analogues. The use of analogues allows 
different areas of the vancomycin molecule to be modified, interactions 
studies would then determine if the modifications are detrimental to the 
formation of aggregates. Thus meaning that area is important in the 
binding between mucin and vancomycin. If the binding area is identified it 
would allow potent vancomycin analogues to be designed that reduces 
mucin aggregation and increase absorption within the GI tract. 
In addition to the use of vancomycin analogues to identify the binding 
mechanism, is an investigation into the use of both positively and 
negatively charged polysaccharides as a drug delivery mechanism. A 
possible investigation could look at the interaction between vancomycin 
and chitosan (positively charged polysaccharide), as chitosan has been 
shown to interact with mucin (Deacon et al., 2000). If chitosan could be 
used to transport vancomycin then it may reduce the formation of 
vancomycin induced aggregates, this may lead to an increased absorption 
of vancomycin.  
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6.3 Mushroom and oat β-glucan 
The investigation in both mushroom and oat β-glucans showed that there 
were considerable differences. Using an array of methods involving 
viscometry, SV, SE and shape determinations, these differences were 
confirmed.  
The investigation showed that mushroom β-glucans have a low intrinsic 
viscosity. Although the actual value obtained from this investigation was 
not obtained, the results suggested that the β-glucans have a low viscosity 
and a resulting molecular weight.  
The SV and SE analysis both supported the claims from the viscosity. The 
sedimentation coefficient was shown to be ~1.4 S, indicative of a small 
molecule. In addition the SE analysis showed that the molecular weight of 
the β-glucans was ~10kDa. The low molecular weight is supportive of 
literature values, however not possible as low as this.  Using the [η], s and 
an array of hydration values, the shape of the β-glucans were determined 
to be extended prolates in all models. 
With regard to the oat β-glucans the intrinsic viscosities were shown to be 
much larger, ranging from 400-1000 mL/g on average. This is immensely 
larger than the intrinsic viscosities of the mushroom β-glucans, however 
literature values suggest that oat β-glucans give rise to viscous solutions. 
The sedimentation coefficients obtained are also consistent with values 
previously found (Woodward et al., 1983). Comparisons of the apparent 
weight average molecular masses (at 1.5 mg/mL) show that all 6 oat β-
glucans have very high molecular weights. 
6.3.1 Future work 
Once the full concentration extrapolations of the apparent weight average 
molecular weights to zero concentration (to eliminate the effects of non-
ideality ) have been performed on the 6 oat β-glucans, full conformation 
analysis using Mark-Houwink analysis can be performed. It will be 
intriguing to see if these molecules conform to a rigid conformation - as 
for the very short mushroom β,1-3, β,1-6 glucans, or (as is more likely) 
are more flexible structures, as seen for other larger β, 1-3, β,1-4 glucans 
from wheat (Li et al., 2006).  
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